Other specified/unspecified inflammatory spondylopathies

M13_SPONDYLINFLAMNAS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M46.8, M46.9 Hospital discharge: ICD-9 — 720[8-9] Cause of death: ICD-10 — M46.8, M46.9 Cause of death: ICD-9 — 720[8-9] 2 out of 7 registries used, show all original rules.	2094
4. Check minimum number of events None	2094
5. Include endpoints None	2094
6. Filter based on genotype QC (FinnGen only)	2030

Control definitions (FinnGen only)

Control exclude: M13_DORSOPATHY

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2

NAME	M13_SPONDYLINFLAMNAS
CONTROL_EXCLUDE	M13_DORSOPATHY
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M46[8-9]
HD_ICD_9	720[8-9]
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M46[8-9]
COD_ICD_9	720[8-9]
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other specified/unspecified inflammatory spondylopathies based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	11100	6611	4434
Only index persons	10586	6400	4186
Unadjusted period prevalence (%)
Whole population	0.16	0.19	0.12
Only index persons	0.21	0.24	0.16
Median age at first event (years)
Whole population	43.02	42.94	43.03
Only index persons	42.21	42.34	42.01

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2030	1367	663
Unadjusted period prevalence (%)	0.43	0.48	0.30
Median age at first event (years)	43.81	43.03	45.42

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2094: Matched controls
20940

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H02AB06

ATC

prednisolone; systemic

5.6

310.1

1465

6139

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

17.4

307.7

406

286

L04AB01

ATC

etanercept; parenteral

41.3

307.7

308

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

16.8

307.7

672

574

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

53.2

307.7

666

182

L04AX03

ATC

methotrexate; systemic

22.8

307.7

1061

904

L88

ICPC

Rheumatoid/seropositive arthritis

21.6

307.7

460

270

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

27.5

307.7

387

171

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

30.2

307.7

387

156

A07EC01

ATC

sulfasalazine; oral, rectal

74.1

307.7

1436

599

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

50.7

307.7

681

197

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

14.8

307.7

574

522

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

157.2

307.7

320

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

52.2

307.7

1493

952

L04AB06

ATC

golimumab; parenteral

77.0

307.7

183

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

28.2

307.7

291

119

M13.9

ICD-10 Finland

Arthritis, unspecified

11.6

307.7

536

605

M45

ICD-10 Finland

Ankylosing spondylitis

927.8

307.7

802

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

4503599627370496.0

307.7

1880

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

391.6

307.7

459

P01BA02

ATC

hydroxychloroquine; oral

8.8

307.7

502

721

L01BA01

ATC

methotrexate; systemic

19.4

307.7

380

236

L04AB04

ATC

adalimumab; parenteral

32.0

307.7

408

157

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

13.7

303.9

299

251

M48.0

ICD-10 Finland

Spinal stenosis

31.1

294.3

195

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

44.3

292.8

175

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

60.5

289.8

162

M46.8

ICD-10 Finland

Other specified inflammatory spondylopathies

+∞

257.8

242

M54.9

ICD-10 Finland

Dorsalgia, unspecified

7.2

244.5

413

693

M54.5

ICD-10 Finland

Low back pain

4.3

231.1

956

3429

L04AA13

ATC

[U] leflunomide

15.5

227.2

204

145

M79.0

ICD-10 Finland

Rheumatism, unspecified

16.6

224.8

194

128

N03AX16

ATC

[U] pregabalin

5.0

217.8

594

1542

N03AX12

ATC

[U] gabapentin; oral

6.2

216.0

426

830

M01AH01

ATC

celecoxib; oral

5.0

212.2

564

1431

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

8.1

211.6

308

436

M01AC06

ATC

meloxicam; systemic, rectal

3.9

208.5

1042

4202

N02AX02

ATC

tramadol; systemic, rectal

3.8

199.5

1031

4224

M54.4

ICD-10 Finland

Lumbago with sciatica

5.5

194.6

439

963

M47.82

ICD-10 Finland

Other spondylosis, cervical region

31.6

191.0

125

M01AH05

ATC

etoricoxib; oral

4.5

190.9

1647

9385

L04AC10

ATC

secukinumab; parenteral

49.5

185.9

108

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

13.3

182.6

178

145

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

16.4

182.0

157

103

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

24.7

179.4

128

L04AB05

ATC

certolizumab pegol; parenteral

44.6

178.2

106

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

10.9

169.2

188

187

M25.5

ICD-10 Finland

Pain in joint

3.4

158.7

943

4089

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

10.1

157.2

185

199

WZA10

NOMESCO Finland

Extensive medical or dental certificate

15.9

148.8

130

M47.9

ICD-10 Finland

Spondylosis, unspecified

64.8

146.8

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

20.4

139.1

107

H20.1

ICD-10 Finland

Chronic iridocyclitis

18.9

135.5

108

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.0

130.9

1025

5075

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

10.7

129.3

144

143

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

3.1

128.4

788

3400

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

22.6

126.3

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

14.4

125.3

115

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.9

122.3

1075

5607

UJF32

NOMESCO Finland

Coloscopy

3.2

119.0

623

2435

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

61.9

118.6

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

36.5

118.3

N06AX21

ATC

duloxetine; oral

4.4

117.7

337

880

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

13.0

117.1

114

M43.1

ICD-10 Finland

Spondylolisthesis

22.7

113.1

A02BC02

ATC

pantoprazole; systemic

3.0

113.0

1526

9817

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

15.3

106.3

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

10.5

106.1

119

M54.6

ICD-10 Finland

Pain in thoracic spine

5.2

103.3

231

492

L03

ICPC

Low back symptom/complaint

2.9

101.0

645

2785

M79.7

ICD-10 Finland

Fibromyalgia

7.7

96.1

139

192

NH3EA

NOMESCO Finland

Feet X-ray examination with load

9.8

95.8

113

121

M03BC01

ATC

orphenadrine (citrate); systemic

2.9

95.1

589

2491

M35.7

ICD-10 Finland

Hypermobility syndrome

13.8

95.1

A02BC03

ATC

lansoprazole; oral

2.8

94.3

652

2921

M03BX02

ATC

tizanidine; oral

2.7

94.2

1467

9706

M54.2

ICD-10 Finland

Cervicalgia

5.0

91.5

208

448

N06AA09

ATC

amitriptyline; systemic

4.6

89.9

230

546

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

12.0

89.1

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

5.2

89.0

194

403

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

3.9

88.1

292

841

NG1DA

NOMESCO Finland

X-ray of knees

14.0

87.3

M01AH02

ATC

rofecoxib; oral

3.9

86.6

284

811

S01BA04

ATC

prednisolone; ophthalmic

9.0

84.0

106

124

M54.3

ICD-10 Finland

Sciatica

7.1

82.0

127

189

M70.6

ICD-10 Finland

Trochanteric bursitis

3.6

79.8

295

912

S01BA01

ATC

dexamethasone; ophthalmic

6.1

76.7

137

236

M54.1

ICD-10 Finland

Radiculopathy

10.9

76.4

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

4.5

76.3

198

474

M01AB05

ATC

diclofenac; systemic, rectal

2.4

73.7

1469

10306

XX9XE

NOMESCO Finland

Other ultrasound examination

15.0

71.8

L40.5

ICD-10 Finland

Arthropathic psoriasis

9.2

71.8

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.5

71.6

595

2862

M01AX01

ATC

nabumetone; oral

6.3

71.2

123

205

M01AB55

ATC

diclofenac, combinations; oral

5.1

71.1

156

325

M50.3

ICD-10 Finland

Other cervical disc degeneration

21.7

71.0

M13.8

ICD-10 Finland

Other specified arthritis

13.0

70.2

WZC30

NOMESCO Finland

Teaching

2.9

70.1

402

1606

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

+∞

69.1

M01AE02

ATC

naproxen; oral, rectal

2.3

68.6

1305

8850

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

+∞

68.1

A02BC01

ATC

omeprazole; systemic

2.5

67.8

574

2775

N02AJ06

ATC

codeine and paracetamol; systemic

2.2

67.2

911

5381

N02BF01

ATC

gabapentin; oral

4.5

67.2

173

411

M01AE03

ATC

ketoprofen; systemic, rectal

2.3

66.6

762

4196

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

26.1

66.2

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

14.9

64.9

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

14.0

64.9

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

12.4

64.4

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

7.0

62.6

144

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

11.3

62.6

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

6.8

62.3

151

N02BE01

ATC

paracetamol; systemic, rectal

3.2

62.1

1876

15248

M53.1

ICD-10 Finland

Cervicobrachial syndrome

3.2

62.0

276

952

TNG10

NOMESCO Finland

Puncture of knee

11.3

61.7

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

10.3

61.3

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

87.9

61.3

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

11.0

61.2

M79.6

ICD-10 Finland

Pain in limb

2.2

61.0

884

5306

A02BC05

ATC

esomeprazole; systemic

2.2

61.0

854

5058

L04AA11

ATC

[U] etanercept

26.8

60.9

L86

ICPC

Back syndrome with radiating pain

5.3

60.8

127

253

M01CB01

ATC

sodium aurothiomalate; parenteral

11.8

59.5

H02AB07

ATC

prednisone; oral

2.9

59.0

327

1275

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

3.4

58.9

228

721

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

12.4

58.4

L04AX01

ATC

azathioprine; systemic

4.4

57.7

152

367

H22.1*M45

ICD-10 Finland

Iridocyclitis in ankylosing spondylitis

+∞

57.6

NH1AE

NOMESCO Finland

Ankle joint ultrasound examination

15.5

57.2

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.1

57.0

870

5292

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

56.9

817

4855

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

14.5

56.3

TPH04

NOMESCO Finland

Cathetrisation of vein

2.4

56.0

466

2212

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.3

55.7

533

2689

7209X

ICD-9 Finland

Ankylosing spondylitis and other inflammatory spondylopathies, Unspecified inflammatory spondylopathy

+∞

55.5

S01FA04

ATC

cyclopentolate; ophthalmic

11.0

55.0

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

7.6

54.9

108

R4110

NOMESCO Finland

Physiotherapy

2.3

54.7

570

2977

M46.0

ICD-10 Finland

Spinal enthesopathy

+∞

54.4

M01AX17

ATC

nimesulide; oral

2.4

53.9

450

2136

M13.0

ICD-10 Finland

Polyarthritis, unspecified

9.0

53.7

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

6.8

52.9

128

S01CA02

ATC

prednisolone and antiinfectives; ophthalmic

12.4

52.3

M54

ICD-10 Finland

Dorsalgia

2.8

52.2

305

1218

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.5

51.7

399

1824

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

3.0

51.2

249

900

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

10.6

51.0

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.7

50.9

300

1203

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.1

50.7

645

3630

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

8.5

50.7

SPAT1301

SPAT

No procedures

2.1

50.5

609

3356

Z01.8

ICD-10 Finland

Other specified special examinations

2.3

50.4

481

2412

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.0

50.4

924

5935

H57.1

ICD-10 Finland

Ocular pain

4.3

49.6

133

325

R51.80

ICD-10 Finland

Headache

2.5

49.5

381

1737

J01AA02

ATC

doxycycline; systemic

2.2

49.2

1611

12640

ZX120

NOMESCO Finland

Intravenous

3.0

47.9

234

847

NA6CG

NOMESCO Finland

Sacro-iliac joint extensive MRI examination with high intensity magnet

104.5

47.0

NF1AA

NOMESCO Finland

Hip X-ray examination

3.7

46.9

157

450

J01FF01

ATC

clindamycin; systemic

2.1

46.8

586

3262

N02BF02

ATC

pregabalin; oral

4.2

46.4

130

328

A01

ICPC

Pain general/multiple sites

3.3

46.0

187

607

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.5

46.0

167

505

M46.4

ICD-10 Finland

Discitis, unspecified

457.4

45.4

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.1

45.3

610

3481

M03BC51

ATC

orphenadrine, combinations; systemic

2.1

45.3

592

3342

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

12.8

45.3

A02BA02

ATC

ranitidine; systemic

2.4

45.2

356

1635

M75.1

ICD-10 Finland

Rotator cuff syndrome

2.2

45.2

478

2488

G44.2

ICD-10 Finland

Tension-type headache

2.5

45.2

324

1426

ZX140

NOMESCO Finland

Intra articular

11.1

45.2

A07EC02

ATC

mesalazine; oral, rectal

3.5

45.0

166

507

H15.1

ICD-10 Finland

Episcleritis

7.3

44.6

N02AC04

ATC

dextropropoxyphene; oral

7.1

44.2

SPAT1249

SPAT

Treatment-related counselling outside office

1.9

43.2

826

5305

ZYC01

NOMESCO Finland

Remote contact by phone

3.4

42.7

166

524

L20

ICPC

Joint symptom/complaint NOS

4.5

42.6

106

244

M01CB03

ATC

auranofin; oral

14.9

42.6

A07EA06

ATC

budesonide; oral, local oral

4.2

42.3

118

297

R52.2

ICD-10 Finland

Other chronic pain

5.2

41.9

172

NA6AA

NOMESCO Finland

Sacro-iliac joint X-ray examination

55.7

41.6

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.9

41.1

691

4238

4AB02, ,

NOMESCO Finland

16.2

41.0

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

+∞

40.8

M01AH03

ATC

valdecoxib; oral

3.7

40.4

134

381

G54.0

ICD-10 Finland

Brachial plexus disorders

5.9

40.3

127

S01FA02

ATC

scopolamine; ophthalmic

12.3

40.2

NE1AA

NOMESCO Finland

Pelvis X-ray examination

3.8

39.9

125

342

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.5

39.6

287

1265

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

7.6

39.6

SPAT1202

SPAT

Intra-articular injection

6.2

39.3

113

M54.8

ICD-10 Finland

Other dorsalgia

4.4

39.2

101

239

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.1

39.2

179

622

L99

ICPC

Musculoskeletal disease other

6.1

39.0

114

R06.0

ICD-10 Finland

Dyspnoea

2.1

38.5

474

2596

L28

ICPC

Limited function/disability (L)

2.5

38.4

260

1109

L04AB02

ATC

infliximab; parenteral

11.0

38.3

H04.10

ICD-10 Finland

Dry eye syndrome

2.5

38.2

270

1175

J01DB01

ATC

cefalexin; oral

2.2

38.2

1748

14637

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.8

38.0

205

780

Z3226

NOMESCO Finland

Physiotherapist

2.3

38.0

351

1719

L02

ICPC

Back symptom/complaint

2.7

37.8

228

919

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

3.3

37.7

146

459

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

3.4

37.7

144

449

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.0

37.7

538

3105

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

2.4

37.1

294

1348

NF1DA

NOMESCO Finland

X-ray of hips

7.2

36.9

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

3.5

36.6

130

387

S18

ICPC

Laceration/cut

1.8

36.5

819

5461

Z50.1

ICD-10 Finland

Other physical therapy

3.8

36.4

115

316

L84

ICPC

Back syndrome without radiat pain

3.8

36.3

112

303

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

4.7

36.1

187

L01

ICPC

Neck symptom/complaint

2.3

36.1

325

1572

M01AB08

ATC

etodolac; oral

3.1

36.0

161

552

J01MA02

ATC

ciprofloxacin; systemic

1.8

36.0

715

4588

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

12.2

35.9

ZXH09, ,

SPAT

4.2

35.9

247

Z71.8

ICD-10 Finland

Other specified counselling

1.9

35.3

674

4266

N06AX16

ATC

venlafaxine; oral

2.2

35.1

328

1609

M02AA07

ATC

piroxicam; topical

1.9

35.1

630

3908

R07.4

ICD-10 Finland

Chest pain, unspecified

2.0

35.1

480

2720

M02.8

ICD-10 Finland

Other reactive arthropathies

12.3

35.1

NGF15

NOMESCO Finland

Total synovectomy of knee, arthroscopic

7.7

34.9

SPAT1263

SPAT

Sampling

1.8

34.7

833

5643

ABC30

NOMESCO Finland

Decompression of cervical nerve roots

+∞

34.5

XA402

NOMESCO Finland

ENMG

6.6

34.1

L17

ICPC

Foot/toe symptom/complaint

1.9

34.1

536

3182

R50.9

ICD-10 Finland

Fever, unspecified

2.2

33.9

315

1541

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

33.7

413

2247

J45.9

ICD-10 Finland

Asthma, unspecified

2.1

33.7

367

1911

H20

ICD-10 Finland

Iridocyclitis

11.5

33.6

R42

ICD-10 Finland

Dizziness and giddiness

2.1

33.4

387

2062

7200A

ICD-9 Finland

Ankylosing spondylitis and other inflammatory spondylopathies, Ankylosing spondylitis

+∞

33.4

N02AA05

ATC

oxycodone; systemic

2.4

33.3

244

1077

R03AC02

ATC

salbutamol; inhalant

1.7

33.2

1133

8453

K02.1

ICD-10 Finland

Caries of dentine

1.8

33.1

1306

10144

A06AC01

ATC

ispaghula (psylla seeds); oral

2.0

33.0

462

2634

M35.3

ICD-10 Finland

Polymyalgia rheumatica

4.8

32.6

158

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

6.8

32.4

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

3.9

32.2

258

M07.3

ICD-10 Finland

Other psoriatic arthropathies

7.3

31.8

ZYC01, ,

SPAT

2.4

31.6

237

1056

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.3

31.6

280

1341

SPAT1153

SPAT

Removal of sutures

1.9

31.6

542

3297

L13

ICPC

Hip symptom/complaint

2.2

31.6

298

1465

M46.3

ICD-10 Finland

Infection of intervertebral disc (pyogenic)

+∞

31.3

7208A

ICD-9 Finland

Ankylosing spondylitis and other inflammatory spondylopathies, Other inflammatory spondylopathies

+∞

31.3

M06

ICD-10 Finland

Other rheumatoid arthritis

9.9

31.3

M01AE52

ATC

naproxen and esomeprazole; oral

4.2

31.2

210

H02AB04

ATC

methylprednisolone; systemic

2.2

30.7

282

1370

P01AB01

ATC

metronidazole; oral, rectal

1.7

30.7

830

5766

E0000UV, ,

ATC

1.7

30.5

864

6074

D07AC01

ATC

betamethasone; topical

1.8

30.4

710

4729

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

5.4

30.2

114

N06AX11

ATC

mirtazapine; oral

1.8

30.1

648

4215

M76.6

ICD-10 Finland

Achilles tendinitis

3.5

30.1

105

309

K07.60

ICD-10 Finland

Snapping jaw

2.9

30.0

143

508

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

5.6

30.0

104

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

8.9

29.8

C07AB07

ATC

bisoprolol; oral

1.7

29.8

731

4930

G47.3

ICD-10 Finland

Sleep apnoea

1.9

29.7

435

2507

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

157.3

29.7

SPAT1260

SPAT

Consultation of another employee

2.1

29.6

330

1727

ZY010, ,

SPAT

6.7

29.4

L04AA01

ATC

[U] ciclosporin

6.8

29.4

M02AA10

ATC

ketoprofen; topical

2.2

29.3

291

1457

J01FA10

ATC

azithromycin; systemic

1.7

29.3

1252

9784

R52.9

ICD-10 Finland

Pain, unspecified

2.5

29.3

192

804

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.0

29.2

343

1831

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.9

29.0

425

2448

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

104.9

28.7

SFA20

NOMESCO Finland

Two-surface restoration

1.7

28.2

1271

10028

R20.2

ICD-10 Finland

Paraesthesia of skin

2.8

28.2

153

583

SAA02

NOMESCO Finland

Basic examination of mouth

1.7

28.1

1452

11872

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

27.6

28.0

R4120

NOMESCO Finland

Occupational therapy

2.8

27.8

146

546

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

5.6

27.8

M01AC01

ATC

piroxicam; systemic, rectal

2.3

27.7

227

1050

ZXH06, ,

SPAT

3.2

27.7

113

367

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.3

27.6

217

986

K50.0

ICD-10 Finland

Crohn disease of small intestine

5.4

27.5

105

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.6

27.5

263

R07.3

ICD-10 Finland

Other chest pain

2.5

27.5

187

796

R03AC03

ATC

terbutaline; inhalant

2.1

27.2

301

1568

L40.0

ICD-10 Finland

Psoriasis vulgaris

3.2

27.2

111

360

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

7.7

27.2

SPAT1310

SPAT

Counselling related to known health issue

1.8

27.2

593

3851

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

5.9

27.2

J02AC01

ATC

fluconazole; systemic

1.7

26.9

868

6257

B01AB05

ATC

enoxaparin; parenteral

1.8

26.9

540

3423

M13.1

ICD-10 Finland

Monoarthritis, not elsewhere classified

6.4

26.6

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

3.3

26.6

103

324

L04AC13

ATC

ixekizumab; parenteral

34.5

26.5

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

7.9

26.4

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

6.8

26.4

N02AJ13

ATC

tramadol and paracetamol; systemic

5.7

26.2

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

37.2

26.2

UJF92

NOMESCO Finland

Capsular endoscopy

4.8

26.0

126

M43.0

ICD-10 Finland

Spondylolysis

40.6

25.8

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

5.9

25.8

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

263.8

25.7

WX110

NOMESCO Finland

Infiltration anesthesia

1.7

25.7

1484

12334

K50.9

ICD-10 Finland

Crohn disease, unspecified

5.2

25.5

105

SAA01

NOMESCO Finland

Simple examination of mouth

1.7

25.5

1527

12801

R03DC03

ATC

montelukast; oral

1.9

25.4

351

1975

ACC51

NOMESCO Finland

Release of median nerve

2.6

25.4

154

620

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.7

25.3

220

ZXA05

NOMESCO Finland

Left side

1.9

25.3

391

2282

ZXA00

NOMESCO Finland

Right side

1.8

25.2

419

2502

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.4

25.1

174

747

SPAT1229

SPAT

Assessment of need for aid

3.0

25.0

116

406

J01DA01

ATC

[U] cefalexin

1.6

25.0

1238

9862

R01AD09

ATC

mometasone; nasal

1.6

24.8

969

7280

J01FA06

ATC

roxithromycin; oral

1.6

24.7

767

5443

J01CA04

ATC

amoxicillin; systemic

1.8

24.7

1722

14981

K50.8

ICD-10 Finland

Other Crohn disease

5.0

24.7

108

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.9

24.6

363

2086

ZXE10

NOMESCO Finland

More than one and less than three hours

1.7

24.6

638

4323

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.3

24.3

192

873

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.1

24.2

260

1338

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

5.9

24.0

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.3

24.0

203

950

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

+∞

24.0

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.6

24.0

734

5182

M25.9

ICD-10 Finland

Joint disorder, unspecified

6.1

23.8

M79.1

ICD-10 Finland

Myalgia

2.0

23.6

297

1616

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

5.4

23.6

L15

ICPC

Knee symptom/complaint

1.8

23.5

417

2534

L04AK01

ATC

leflunomide; oral

8.9

23.3

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

3.4

23.2

258

M01AB01

ATC

indometacin; systemic, rectal

2.9

23.2

109

384

M05BA04

ATC

alendronic acid; oral

2.7

23.0

125

476

9211

FHL

Exploration or removal of diskusprolapse

+∞

23.0

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

7.4

22.9

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.7

22.8

131

513

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

22.8

339

1949

UJF30

NOMESCO Finland

Ileoscopy through colon

2.2

22.7

202

965

SFA10

NOMESCO Finland

One-surface restoration

1.6

22.4

1138

9016

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

5.1

22.4

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.4

22.4

163

715

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.0

22.3

247

1284

N05BA01

ATC

diazepam; systemic, rectal

2.1

22.2

233

1187

WZC00, ,

SPAT

2.2

22.2

205

994

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.2

22.1

187

875

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.0

21.8

267

1438

M01AE01

ATC

ibuprofen; systemic, rectal

2.1

21.8

1913

17402

M53.2

ICD-10 Finland

Spinal instabilities

81.0

21.7

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.2

21.6

188

890

SAA03

NOMESCO Finland

Extended examination of mouth

1.6

21.5

817

6035

WZA90

NOMESCO Finland

Other medical or dental certificate

1.7

21.5

455

2903

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

6.6

21.3

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

21.2

355

2116

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

3.6

21.1

199

TNF11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in hip joint

34.2

21.1

R4180

NOMESCO Finland

Podiatric therapy

5.8

21.0

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

6.5

20.9

Z01.2

ICD-10 Finland

Dental examination

1.6

20.9

934

7149

L04AA17

ATC

[U] adalimumab

21.7

20.8

NA6BM

NOMESCO Finland

Sacro-iliac joint MRI examination with 3 Tesla magnet

77.6

20.7

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

20.6

1054

8299

NDL52

NOMESCO Finland

Tenosynovectomy of hand

8.3

20.5

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.4

20.5

140

596

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.2

20.4

191

931

WZC30, ,

SPAT

2.8

20.3

106

395

M77.9

ICD-10 Finland

Enthesopathy, unspecified

3.2

20.2

260

H02BX01

ATC

methylprednisolone, combinations; systemic

3.3

20.1

246

M07.4*K50.9

ICD-10 Finland

Arthropathy in Crohn's disease [regional enteritis]

27.3

20.0

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.7

20.0

111

428

71240

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Spondylitis ankylopoietica

+∞

19.8

J04AB02

ATC

rifampicin; systemic

6.3

19.8

J45.1

ICD-10 Finland

Nonallergic asthma

2.5

19.7

129

539

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

5.9

19.6

R06AE07

ATC

cetirizine; oral

1.5

19.6

899

6886

M46

ICD-10 Finland

Other inflammatory spondylopathies

201.8

19.6

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

4.3

19.6

122

SFA30

NOMESCO Finland

Three-surface restoration

1.5

19.5

826

6216

C08CA01

ATC

amlodipine; oral

1.6

19.5

526

3564

ZXE00

NOMESCO Finland

One hour or less

1.6

19.5

740

5436

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

2.6

19.5

114

451

Z3231

NOMESCO Finland

Registered nurse

1.7

19.2

465

3063

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

2.4

19.2

130

551

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.2

19.2

170

810

L16

ICPC

Ankle symptom/complaint

2.0

19.1

220

1157

NHL50

NOMESCO Finland

Tenolysis or tenosynovectomy of foot

22.8

19.1

N05BA04

ATC

oxazepam; oral

1.7

19.0

465

3073

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.7

18.9

471

3124

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.5

18.9

1117

9007

OAB42, ,

SPAT

2.0

18.8

212

1106

NF2AT

NOMESCO Finland

Injection to hip joint with ultrasound guidance

16.0

18.8

AA1AD

NOMESCO Finland

CT of head and brain

1.7

18.7

374

2341

M02.1

ICD-10 Finland

Postdysenteric arthropathy

21.0

18.6

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

6.3

18.5

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

3.2

18.5

243

A03FA01

ATC

metoclopramide; systemic, rectal

1.7

18.4

404

2590

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

15.2

18.4

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.2

18.4

154

716

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

18.4

1094

8809

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

18.4

472

3153

R01AD12

ATC

fluticasone furoate; nasal

1.5

18.3

688

5029

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.0

18.2

202

1049

D07AB02

ATC

hydrocortisone butyrate; topical

1.6

18.2

560

3910

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

18.1

946

7410

C03CA01

ATC

furosemide; systemic

1.8

18.1

322

1948

TQW40, ,

SPAT

2.3

17.9

140

633

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.6

17.9

104

410

N05CF01

ATC

zopiclone; oral

1.6

17.9

513

3520

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.9

17.8

291

N06AA10

ATC

nortriptyline; systemic

4.4

17.8

105

RF120, ,

NOMESCO Finland

7.0

17.8

M07.5*K51.9

ICD-10 Finland

Arthropathy in ulcerative colitis

18.2

17.8

D07AD01

ATC

clobetasol; topical

1.8

17.8

306

1832

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.7

17.7

353

2203

R74

ICPC

Upper respiratory infection acute

1.5

17.7

706

5216

C01CA24

ATC

epinephrine; parenteral

2.2

17.6

152

716

N03AE01

ATC

clonazepam; systemic

2.6

17.5

385

D05AX52

ATC

calcipotriol, combinations; topical

2.5

17.5

110

451

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

2.5

17.4

115

482

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.7

17.4

413

2701

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.1

17.4

163

794

L04AD01

ATC

ciclosporin; systemic

4.0

17.3

125

M06.4

ICD-10 Finland

Inflammatory polyarthropathy

14.0

17.3

R01BA52

ATC

pseudoephedrine, combinations; oral

1.6

17.2

564

3987

M70.7

ICD-10 Finland

Other bursitis of hip

4.0

17.1

126

F01

ICPC

Eye pain

3.3

17.0

198

WX290

NOMESCO Finland

Other blockage of nerve

1.5

17.0

1020

8179

A01AB09

ATC

miconazole; local oral

2.2

17.0

145

680

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

17.0

677

4993

SPAT1325

SPAT

Vaccination

1.6

16.9

514

3567

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.9

16.9

230

1279

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.3

16.9

137

629

ZXA10

NOMESCO Finland

Bilateral

1.8

16.9

285

1695

R02

ICPC

Shortness of breath/dyspnoea

2.0

16.9

191

998

K07.69

ICD-10 Finland

Dislocation of the jaw joint UNS

4.5

16.9

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

63.9

16.7

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.2

16.7

143

671

NDG60

NOMESCO Finland

Arthroplasty of first CMC joint

5.5

16.7

M19.2

ICD-10 Finland

Other secondary arthrosis

5.5

16.7

R01AD08

ATC

fluticasone; nasal

1.5

16.6

586

4206

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

4.0

16.6

120

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

4.0

16.6

120

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.0

16.5

181

934

J20

ICD-10 Finland

Acute bronchitis

2.0

16.5

187

977

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

5.1

16.5

R03BA02

ATC

budesonide; inhalant

1.7

16.4

338

2125

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

3.0

16.4

250

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.8

16.4

258

1503

R06AX27

ATC

desloratadine; oral

1.5

16.2

612

4451

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

5.1

16.2

J01FA09

ATC

clarithromycin; systemic

1.5

16.0

599

4346

G43.9

ICD-10 Finland

Migraine, unspecified

2.2

16.0

143

683

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

24.7

16.0

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

16.0

820

6351

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

16.0

428

2879

XKD00

NOMESCO Finland

Uroflowmetry

2.1

15.9

164

828

SPAT1255

SPAT

Intravenous administration of medicine

2.4

15.9

112

484

ZY010

NOMESCO Finland

Hospital outpatient

2.3

15.9

120

535

K30

ICD-10 Finland

Functional dyspepsia

1.9

15.8

205

1121

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.2

15.8

207

R5140

NOMESCO Finland

Monitoring the use of the aid

2.0

15.8

184

970

K51.5

ICD-10 Finland

Left sided colitis

2.9

15.8

266

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

15.8

217

1210

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

33.6

15.7

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.8

15.7

241

1391

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.7

15.7

330

2085

C07AB02

ATC

metoprolol; systemic

1.8

15.7

255

1498

R51

ICD-10 Finland

Headache

2.3

15.7

120

538

C07AA05

ATC

propranolol; systemic

1.6

15.6

404

2692

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

5.3

15.6

R1250

NOMESCO Finland

Evaluation of functional capability

3.8

15.6

130

R5599

NOMESCO Finland

Other rehabilitation service

3.9

15.6

121

X58

ICD-10 Finland

Exposure to other specified factors

1.8

15.5

265

1579

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.0

15.5

174

905

C01DA14

ATC

isosorbide mononitrate; oral

2.2

15.5

135

638

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.2

15.5

128

592

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.2

15.5

136

645

R00.2

ICD-10 Finland

Palpitations

2.1

15.5

158

795

K50.1

ICD-10 Finland

Crohn disease of large intestine

4.4

15.5

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.8

15.4

278

1683

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

5.4

15.4

J05AB01

ATC

aciclovir; systemic

1.6

15.4

418

2816

A02BX02

ATC

sucralfate; oral

3.2

15.4

200

WX002

NOMESCO Finland

Sedation and analgesia

1.7

15.4

300

1856

M65.8

ICD-10 Finland

Other synovitis and tenosynovitis

3.2

15.4

195

NHL16

NOMESCO Finland

Tenolysis or tenosynovectomy of achilles tendon

38.3

15.4

C10AC01

ATC

colestyramine; oral

3.4

15.4

165

L18

ICPC

Muscle pain

2.8

15.3

277

OAB47, ,

SPAT

2.3

15.2

120

545

D01

ICPC

Abdominal pain/cramps general

1.9

15.2

219

1240

L08

ICPC

Shoulder symptom/complaint

1.7

15.2

353

2289

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

2.5

15.2

413

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.6

15.2

365

A07AA02

ATC

nystatin; oral

2.5

15.2

383

S01BC03

ATC

diclofenac; ophthalmic

3.5

15.1

152

M47.81

ICD-10 Finland

Other spondylosis, occipito-atlanto-axial region

20.2

15.1

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.1

15.1

151

754

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.7

15.1

296

L03.0

ICD-10 Finland

Cellulitis of finger and toe

2.0

15.0

164

845

SBB10

NOMESCO Finland

Dental impressions

2.2

15.0

133

633

R07.0

ICD-10 Finland

Pain in throat

2.1

15.0

152

763

RF420, ,

NOMESCO Finland

5.4

15.0

R21

ICPC

Throat symptom/complaint

1.6

15.0

448

3088

M17.5

ICD-10 Finland

Other secondary gonarthrosis

4.6

14.9

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

4.1

14.9

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

3.0

14.9

220

OAB25, ,

SPAT

6.8

14.9

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.9

14.9

253

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.5

14.8

515

3668

TAB00

NOMESCO Finland

Lumbar puncture

2.6

14.8

357

D07XC01

ATC

betamethasone; topical

1.9

14.8

212

1198

M65.9

ICD-10 Finland

Synovitis and tenosynovitis, unspecified

2.9

14.8

254

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.5

14.7

518

3702

4AB0M, ,

NOMESCO Finland

+∞

14.6

72880

ICD-8 Finland

Vertebrogenic pain syndrome, Radicula syndrome of lower limbs

+∞

14.6

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

14.5

842

6640

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

14.3

14.5

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

4.8

14.5

N04BC05

ATC

pramipexole; oral

2.3

14.5

106

466

FP1C5

NOMESCO Finland

Resting ECG, 15 leads

5.8

14.5

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.8

14.5

237

1395

R03AC12

ATC

salmeterol; inhalant

2.8

14.4

252

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

3.9

14.3

110

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

6.0

14.3

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

6.0

14.3

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

11.4

14.3

D64.9

ICD-10 Finland

Anaemia, unspecified

2.1

14.3

135

660

M16.7

ICD-10 Finland

Other secondary coxarthrosis

6.2

14.2

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.3

14.2

113

515

XA800

NOMESCO Finland

Neuropsychological investigation

2.6

14.2

341

UDC00

NOMESCO Finland

Ear microscopy

2.1

14.2

139

689

N06AB04

ATC

citalopram; systemic

1.6

14.1

360

2385

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.7

14.1

312

1994

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.9

14.1

171

914

Z3229

NOMESCO Finland

Other healthcare associate professional

2.1

14.1

135

663

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.9

14.1

176

951

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.0

14.0

149

761

R01AD58

ATC

fluticasone, combinations; nasal

1.5

13.9

528

3824

M53.3

ICD-10 Finland

Sacrococcygeal disorders, not elsewhere classified

5.2

13.9

R53

ICD-10 Finland

Malaise and fatigue

1.6

13.9

412

2830

A03

ICPC

Fever

1.6

13.8

343

2257

UKC02

NOMESCO Finland

Cystoscopy

1.9

13.8

186

1030

J45

ICD-10 Finland

Asthma

1.9

13.8

190

1060

J35.0

ICD-10 Finland

Chronic tonsillitis

2.1

13.8

133

655

WW200

NOMESCO Finland

Immunization

3.0

13.8

214

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

2.4

13.7

383

L12

ICPC

Hand/finger symptom/complaint

1.7

13.7

277

1730

72510

ICD-8 Finland

Displacement of intervertebral disk, Lumbalis cum prolapsu disci

+∞

13.6

K59.1

ICD-10 Finland

Functional diarrhoea

2.3

13.5

429

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.7

13.5

272

R03BA01

ATC

beclometasone; inhalant

1.8

13.5

231

1376

J05AB11

ATC

valaciclovir; oral

1.7

13.5

263

1625

M48.1

ICD-10 Finland

Ankylosing hyperostosis [Forestier]

140.9

13.5

J01MA14

ATC

moxifloxacin; systemic

2.0

13.5

145

744

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

13.4

325

2124

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.6

13.3

315

SPAT1312

SPAT

General health counselling

1.5

13.3

565

4181

J01MA12

ATC

levofloxacin; systemic

1.7

13.3

272

1704

A07EA02

ATC

hydrocortisone; rectal

3.1

13.2

176

M01AX05

ATC

glucosamine; oral

1.8

13.2

220

1300

N07CA01

ATC

betahistine; oral

2.2

13.2

107

492

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

13.1

108

500

R09

ICPC

Sinus symptom/complaint

1.9

13.1

169

923

RF410, ,

NOMESCO Finland

5.5

13.1

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.7

13.1

244

1490

SPAT1058

SPAT

PEF monitoring instruction

2.1

13.0

122

595

SPAT1131

SPAT

Colonoscopy

3.1

13.0

173

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.6

13.0

284

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

13.0

478

3436

M05BX04

ATC

denosumab; parenteral

2.6

12.9

308

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

4.0

12.9

M02.3

ICD-10 Finland

Reiter disease

19.2

12.9

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.1

12.8

129

645

WX402

NOMESCO Finland

General anaesthesia

1.6

12.8

377

2579

R13

ICD-10 Finland

Dysphagia

2.2

12.8

103

472

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

12.8

149

786

M76.9

ICD-10 Finland

Enthesopathy of lower limb, unspecified

5.4

12.8

R10.0

ICD-10 Finland

Acute abdomen

2.7

12.7

246

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.9

12.7

180

1012

LCA06

NOMESCO Finland

Biopsy of endometrium

1.7

12.7

241

1477

EB1VA, ,

NOMESCO Finland

1.7

12.7

239

1462

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

3.5

12.7

125

R05

ICPC

Cough

1.5

12.6

402

2799

M05BB03

ATC

alendronic acid and colecalciferol; oral

4.2

12.5

G99.2*M47.1

ICD-10 Finland

Spondylogenic compression of spinal cord

+∞

12.5

7245A

ICD-9 Finland

Other and unspecified disorders of back, Backache, unspecified

+∞

12.5

M46.5

ICD-10 Finland

Other infective spondylopathies

+∞

12.5

K80

ICPC

Cardiac arrhythmia NOS

2.1

12.5

125

624

R03BA08

ATC

ciclesonide; inhalant

1.9

12.5

161

879

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

2.7

12.5

249

M46.2

ICD-10 Finland

Osteomyelitis of vertebra

130.8

12.4

M48.9

ICD-10 Finland

Spondylopathy, unspecified

130.8

12.4

R52.1

ICD-10 Finland

Chronic intractable pain

13.2

12.4

O99.1

ICD-10 Finland

Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium

5.1

12.4

R05

ICD-10 Finland

Cough

1.6

12.4

360

2454

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

4.5

12.4

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.3

12.4

427

E66.01

ICD-10 Finland

Obesity due to excess calories

1.8

12.3

184

1053

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

3.8

12.3

K08.80

ICD-10 Finland

Toothache NOS

1.8

12.3

185

1061

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.5

12.3

316

NA3BM

NOMESCO Finland

Lumbar spine MRI examination with 3 Tesla magnet

37.8

12.2

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

4.3

12.2

J31.0

ICD-10 Finland

Chronic rhinitis

1.9

12.1

160

881

WW200, ,

SPAT

1.5

12.1

397

2781

G44.8

ICD-10 Finland

Other specified headache syndromes

3.7

12.1

105

Z2446

NOMESCO Finland

Social worker

2.1

12.0

115

565

Z02.7

ICD-10 Finland

Issue of medical certificate

2.1

12.0

116

572

NG2CA

NOMESCO Finland

X-ray of patella with specialised projection

9.3

12.0

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.9

12.0

167

935

SPAT1097

SPAT

Recording of ECG

1.8

11.9

194

1138

D07AC13

ATC

mometasone; topical

1.5

11.9

516

3821

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

11.9

395

2771

1220

FHL

Arthroscopy

2.7

11.9

232

SCA01

NOMESCO Finland

Preventive oral health care, short

1.4

11.9

563

4241

M07.4

ICD-10 Finland

Arthropathy in Crohn disease [regional enteritis]

46.9

11.9

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

2.8

11.9

221

ZXE20

NOMESCO Finland

More than three and less than five hours

1.8

11.9

194

1140

R83

ICPC

Respiratory infection other

1.4

11.8

572

4325

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

5.4

11.8

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.9

11.8

156

859

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.9

11.7

162

904

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.9

11.7

150

817

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.4

11.7

1096

9274

SDA03

NOMESCO Finland

Periodontal treatment

1.4

11.7

804

6465

R60.0

ICD-10 Finland

Localized oedema

1.9

11.7

155

854

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.1

11.7

118

592

R61.9

ICD-10 Finland

Hyperhidrosis, unspecified

4.6

11.7

A46

ICD-10 Finland

Erysipelas

1.8

11.6

192

1132

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

3.1

11.6

158

E000006, ,

ATC

2.1

11.6

114

566

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

11.6

488

3593

C09CA01

ATC

losartan; oral

1.5

11.6

348

2389

CJB10

NOMESCO Finland

Laser discission of secondary cataract

2.3

11.5

388

L29

ICPC

Musculoskeletal sympt/complt other

2.0

11.5

131

685

H53.1

ICD-10 Finland

Subjective visual disturbances

2.1

11.5

116

581

J01FA01

ATC

erythromycin; systemic

1.6

11.5

290

1912

M25.4

ICD-10 Finland

Effusion of joint

3.8

11.5

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.4

11.5

345

72870

ICD-8 Finland

Vertebrogenic pain syndrome, Lumbalgia

+∞

11.5

NA7BT

NOMESCO Finland

Injection to spinal facet joint with radiological guidance

120.7

11.4

P06

ICPC

Sleep disturbance

1.7

11.4

212

1291

QXB99, ,

SPAT

3.5

11.4

114

S06.0

ICD-10 Finland

Concussion

1.8

11.4

174

1002

KMAK, ,

NOMESCO Finland

1.4

11.4

1043

8781

R03AC13

ATC

formoterol; inhalant

2.3

11.3

353

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.6

11.3

244

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

2.0

11.3

118

599

M79.9

ICD-10 Finland

Soft tissue disorder, unspecified

5.2

11.3

L34

ICPC

Musculoskeletal, Blood test

35.2

11.3

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

11.2

190

1127

RS221, ,

NOMESCO Finland

4.0

11.2

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

2.8

11.2

194

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.0

11.2

120

615

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.1

11.2

151

WX780

NOMESCO Finland

Remote monitoring CPAP

2.3

11.1

394

TNH10

NOMESCO Finland

Joint puncture, ankle joint or foot joint

25.2

11.1

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

11.1

154

860

R60.9

ICD-10 Finland

Oedema, unspecified

2.4

11.1

331

J46

ICD-10 Finland

Status asthmaticus

3.0

11.1

157

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.5

11.1

424

3060

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.8

11.0

156

877

L04AC07

ATC

tocilizumab; parenteral

11.2

11.0

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.4

11.0

339

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.4

11.0

520

3909

A03FA02

ATC

cisapride; oral, rectal

2.1

11.0

476

TQW80

NOMESCO Finland

Local dermatologic skincare

2.9

10.9

169

C08DA01

ATC

verapamil; systemic

2.6

10.9

231

G06.1

ICD-10 Finland

Intraspinal abscess and granuloma

43.5

10.9

J01CF05

ATC

flucloxacillin; systemic

2.0

10.9

113

572

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.7

10.9

214

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

2.0

10.9

118

607

SPAT1240

SPAT

Therapeutic discussion

1.7

10.8

211

1302

M50.9

ICD-10 Finland

Cervical disc disorder, unspecified

15.6

10.8

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.4

10.8

298

SPAT1081

SPAT

Cardiorespiratory global assessment

2.4

10.8

292

R03BA05

ATC

fluticasone; inhalant

1.6

10.8

316

2154

TND10

NOMESCO Finland

Joint puncture, wrist or finger joint

10.6

10.8

OAA65, ,

SPAT

1.5

10.8

390

2782

NBG10

NOMESCO Finland

Acromioplastia

3.8

10.8

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

3.6

10.8

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

3.0

10.7

160

F51.0

ICD-10 Finland

Nonorganic insomnia

1.5

10.7

315

2148

36400

ICD-8 Finland

Iritis, Iridocyclitis acuta

17.9

10.7

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.1

10.7

104

514

NK4AT

NOMESCO Finland

Puncture of joint with ultrasound guidance not elsewher classified

5.6

10.7

ZXD05

NOMESCO Finland

Urgent procedure

1.4

10.7

538

4086

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

3.3

10.7

119

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.8

10.7

178

1052

M04AA01

ATC

allopurinol; systemic

1.9

10.7

140

769

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

13.0

10.6

C10AA03

ATC

pravastatin; oral

2.3

10.6

357

-1, ,

NOMESCO Finland

1.4

10.6

636

4978

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

10.6

409

2953

B01AB04

ATC

dalteparin; parenteral

2.2

10.6

383

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

10.6

618

4815

N05CF02

ATC

zolpidem; oral

1.6

10.6

296

1996

H20.8

ICD-10 Finland

Other iridocyclitis

8.0

10.6

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.2

10.6

130

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.4

10.4

666

5265

G99.2*M51.0

ICD-10 Finland

Lumbar and other intervertebral disc disorders with myelopathy

+∞

10.4

M03.2*A04.6

ICD-10 Finland

Postinfectious arthropathy in enteritis due to Yersinia enterocolitica

+∞

10.4

ABC60

NOMESCO Finland

Decompression of cervical spinal cord

+∞

10.4

S21

ICPC

Skin texture symptom/complaint

1.7

10.4

207

1284

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.6

10.4

237

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.3

10.4

367

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.7

10.4

208

D06

ICPC

Abdominal pain localized other

1.8

10.3

146

821

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

5.2

10.3

NA3CG, ,

SPAT

4.3

10.3

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.5

10.3

102

71599

ICD-8 Finland

Arthritis, unspecified

18.9

10.3

A02BB01

ATC

misoprostol; oral

18.9

10.3

SPAT1284

SPAT

Extensive health certificate

2.7

10.2

198

M23.8

ICD-10 Finland

Other internal derangements of knee

2.4

10.2

312

C08CA13

ATC

lercanidipine; oral

1.7

10.2

176

1050

W19

ICD-10 Finland

Unspecified fall

1.8

10.2

140

781

N06AX03

ATC

mianserin; oral

2.4

10.1

301

WX320

NOMESCO Finland

Spinalanesthesy

1.5

10.1

372

2658

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

2.2

10.1

384

P01

ICPC

Feeling anxious/nervous/tense

1.6

10.1

248

1623

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.4

10.1

277

VALMI, ,

NOMESCO Finland

1.4

10.0

470

3518

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.8

10.0

164

964

M01AE51

ATC

ibuprofen, combinations; systemic

4.8

10.0

J01FA15

ATC

telithromycin; oral

1.7

10.0

179

1079

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

4.6

10.0

TNC11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in elbow joint

14.6

10.0

RT272, ,

NOMESCO Finland

14.6

10.0

NA1CM

NOMESCO Finland

Cervical spine extensive MRI examination with 3 Tesla magnet

40.3

10.0

M76.0

ICD-10 Finland

Gluteal tendinitis

3.6

9.9

J01DA09

ATC

[U] cefadroxil

1.4

9.9

479

3606

E000001, ,

ATC

1.5

9.9

356

2534

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

3.9

9.9

M09AX01

ATC

hyaluronic acid; parenteral

2.7

9.9

185

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.6

9.8

220

4AA12, ,

NOMESCO Finland

8.1

9.8

M22.4

ICD-10 Finland

Chondromalacia patellae

2.4

9.8

262

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

9.8

209

1320

M07.2*L40.5

ICD-10 Finland

Psoriatic spondylitis

20.1

9.8

M05BA06

ATC

ibandronic acid; systemic

3.7

9.7

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.7

9.7

196

1222

M51.2

ICD-10 Finland

Other specified intervertebral disc displacement

55.3

9.6

AB5CT

NOMESCO Finland

Blockage of nerv root with CT guidance

55.3

9.6

3640A

ICD-9 Finland

Disorders of iris and ciliary body, Acute and subacute iridocyclitis

55.3

9.6

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

9.6

232

1510

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

2.3

9.6

340

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

3.2

9.6

117

NA1BG, ,

SPAT

3.3

9.6

112

C08CA05

ATC

nifedipine; systemic

2.2

9.6

360

JN3AD

NOMESCO Finland

Abdominal CT examination

1.7

9.6

166

992

EBA00

NOMESCO Finland

Extraction of tooth

1.4

9.6

637

5058

M77.4

ICD-10 Finland

Metatarsalgia

1.9

9.5

111

586

RS222, ,

NOMESCO Finland

4.6

9.5

J01EA01

ATC

trimethoprim; systemic

1.4

9.5

415

3062

M53.9

ICD-10 Finland

Dorsopathy, unspecified

9.1

9.5

Y83.1

ICD-10 Finland

Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.8

9.5

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.8

9.5

130

724

M01AC02

ATC

tenoxicam; systemic, rectal

2.4

9.5

254

-1, ,

ICPC

2.4

9.5

254

R49.01

ICD-10 Finland

Functional dysphonia

2.5

9.5

230

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

9.5

167

1003

H81.0

ICD-10 Finland

Ménière disease

3.2

9.5

113

RF210, ,

NOMESCO Finland

2.7

9.4

178

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

100.5

9.4

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

9.4

567

4427

Z01.9

ICD-10 Finland

Special examination, unspecified

2.1

9.4

443

OAB93, ,

SPAT

1.8

9.4

134

756

M41.1

ICD-10 Finland

Juvenile idiopathic scoliosis

+∞

9.4

XF600

NOMESCO Finland

Bloodpressure measurement

2.1

9.4

430

M07.5

ICD-10 Finland

Arthropathy in ulcerative colitis

21.8

9.3

SPAT1254

SPAT

Administration of medicine

1.7

9.3

192

1202

M77.8

ICD-10 Finland

Other enthesopathies, not elsewhere classified

4.9

9.3

H01

ICPC

Ear pain/earache

1.6

9.3

198

1250

M53.8

ICD-10 Finland

Other specified dorsopathies

8.7

9.3

G72.9

ICD-10 Finland

Myopathy, unspecified

8.7

9.3

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

2.7

9.2

180

D07AB08

ATC

desonide; topical

1.7

9.2

189

1181

XKC03

NOMESCO Finland

Water cystometry

2.9

9.2

152

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.8

9.2

152

895

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.8

9.2

127

710

TCF00

NOMESCO Finland

Subconjunctival therapeutic injection

13.7

9.2

WX204

NOMESCO Finland

Axillary plexus blockaced

2.4

9.2

246

N05AH04

ATC

quetiapine; oral

1.5

9.1

300

2092

R03BB01

ATC

ipratropium bromide; inhalant

2.8

9.1

153

G03DB01

ATC

dydrogesterone; oral

1.6

9.1

255

1718

S80.0

ICD-10 Finland

Contusion of knee

1.8

9.1

133

756

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

5.0

9.1

L11

ICPC

Wrist symptom/complaint

1.7

9.1

155

922

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.3

9.1

297

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.9

9.1

123

683

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

3.5

9.1

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

4.6

9.1

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.7

9.1

155

923

R51.81

ICD-10 Finland

Facial pain NOS

2.8

9.0

165

N06AB10

ATC

escitalopram; oral

1.4

9.0

391

2879

G55.1

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders

15.6

9.0

RK220, ,

NOMESCO Finland

9.1

9.0

7140B

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SERONEGATIVA]

9.1

9.0

H15.0

ICD-10 Finland

Scleritis

10.1

9.0

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

2.0

9.0

478

S92.3

ICD-10 Finland

Fracture of metatarsal bone

2.3

9.0

311

M01AG02

ATC

tolfenamic acid; oral, rectal

1.5

9.0

284

1965

K59.0

ICD-10 Finland

Constipation

2.2

9.0

344

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

9.0

493

J01

ICD-10 Finland

Acute sinusitis

1.9

8.9

110

592

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.0

8.9

507

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.1

8.9

404

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

2.2

8.9

351

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.3

8.9

312

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

7.5

8.9

K51.8

ICD-10 Finland

Other ulcerative colitis

3.2

8.9

107

ZX114

NOMESCO Finland

Intramuscular

3.4

8.9

H26.4

ICD-10 Finland

After-cataract

2.0

8.9

494

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

2.6

8.8

196

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

8.8

107

573

Z2445

NOMESCO Finland

Psychologist

2.2

8.8

346

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.9

8.8

110

595

M65.3

ICD-10 Finland

Trigger finger

2.1

8.8

373

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

3.4

8.8

EMB10

NOMESCO Finland

Tonsillectomy

1.8

8.7

126

714

E66.8

ICD-10 Finland

Other obesity

1.9

8.7

107

576

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.9

8.7

106

569

F32.1

ICD-10 Finland

Moderate depressive episode

1.8

8.7

126

715

NA3CM

NOMESCO Finland

Lumbar spine extensive MRI examination with 3 Tesla magnet

50.2

8.7

NHL68

NOMESCO Finland

Tenodesis, shortening or lengthening of tendon of foot

4.3

8.7

L30.3

ICD-10 Finland

Infective dermatitis

2.3

8.6

278

SFA00

NOMESCO Finland

Small restoration

1.5

8.6

244

1647

R11

ICD-10 Finland

Nausea and vomiting

1.8

8.6

130

746

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

8.6

671

5439

B35.3

ICD-10 Finland

Tinea pedis

2.1

8.6

383

M01AB16

ATC

aceclofenac; oral

2.6

8.6

181

N41.9

ICD-10 Finland

Inflammatory disease of prostate, unspecified

4.4

8.6

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.7

8.6

142

837

U05

ICPC

Urination problems other

2.3

8.6

266

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.7

8.6

164

S01XA18

ATC

ciclosporin; ophthalmic

4.6

8.6

R01AD11

ATC

triamcinolone; nasal

1.7

8.6

155

938

R01AD01

ATC

beclometasone; nasal

1.5

8.5

273

1893

M10.9

ICD-10 Finland

Gout, unspecified

2.2

8.5

338

J45.8

ICD-10 Finland

Mixed asthma

2.6

8.5

182

R99

ICPC

Respiratory disease other

3.2

8.5

100

RT271, ,

NOMESCO Finland

27.6

8.5

K59.09

ICD-10 Finland

Constipation, unspecified

2.1

8.5

352

N05BB01

ATC

hydroxyzine; systemic

1.9

8.5

114

632

R03AK08

ATC

formoterol and beclometasone; inhalant

2.1

8.5

359

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

8.4

387

2877

M05BA07

ATC

risedronic acid; oral

3.1

8.4

116

H02AB09

ATC

hydrocortisone; systemic

2.7

8.4

160

D94

ICPC

Chronic enteritis/ulcerative colitis

4.3

8.4

N05CD07

ATC

temazepam; oral

1.8

8.4

131

760

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.9

8.4

100

533

SPAT1377

SPAT

Polysomnography

2.3

8.4

263

R75

ICPC

Sinusitis acute/chronic

2.0

8.4

470

EGA00

NOMESCO Finland

Arthroscopy of mandibular joint

12.8

8.4

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.0

8.4

415

M66.0

ICD-10 Finland

Rupture of popliteal cyst

3.8

8.3

4AB0X, ,

NOMESCO Finland

+∞

8.3

H22.1

ICD-10 Finland

Iridocyclitis in other diseases classified elsewhere

+∞

8.3

0381A

ICD-9 Finland

Septicaemia, Staphylococcal septicaemia[SEPTICHAEMIA STAPHYLOCOCCUS AUREUS]

+∞

8.3

7231A

ICD-9 Finland

Other disorders of cervical region, Cervicalgia

+∞

8.3

NA6AG, ,

NOMESCO Finland

+∞

8.3

S97

ICPC

Chronic ulcer skin

2.2

8.3

328

S89.9

ICD-10 Finland

Unspecified injury of lower leg

2.2

8.3

302

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.0

8.3

457

A06AD11

ATC

lactulose; oral

1.7

8.3

160

984

NXL00

NOMESCO Finland

Biopsy of muscle

10.8

8.3

SPAT1216

SPAT

Assessment of functional ability

1.7

8.3

166

1032

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.6

8.3

227

1522

-50

ICPC

Medication/prescr/renewal

2.3

8.3

258

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

9.5

8.3

RD210, ,

NOMESCO Finland

3.2

8.2

102

A02BC04

ATC

rabeprazole; oral

1.7

8.2

148

894

D48.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage

3.4

8.2

Z2221

NOMESCO Finland

Medical doctor

1.4

8.2

475

3673

AN1

Coronary angiography

1.9

8.2

523

K29.7

ICD-10 Finland

Gastritis, unspecified

2.4

8.2

222

L92

ICPC

Shoulder syndrome

2.9

8.2

129

NA2BG, ,

SPAT

6.5

8.2

N06AX12

ATC

bupropion; oral

1.7

8.2

146

881

R06.5

ICD-10 Finland

Mouth breathing

1.7

8.1

150

912

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.8

8.1

146

WX200

NOMESCO Finland

Interscalenous plexus blockade

3.1

8.1

108

R06AE09

ATC

levocetirizine; oral

1.5

8.1

281

1980

R5110, ,

SPAT

2.1

8.1

372

J01DA06

ATC

[U] cefuroxime

1.5

8.1

247

1695

A04

ICPC

Weakness/tiredness general

1.6

8.1

213

1415

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

2.1

8.1

379

G50.1

ICD-10 Finland

Atypical facial pain

3.4

8.1

NA3CF

NOMESCO Finland

Lumbar spine extensive MRI examination with median intensity magnet

33.5

8.1

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

17.2

8.1

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

8.0

150

915

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.9

8.0

477

298, ,

Kela drug reimbursment

10.1

8.0

205

Kela drug reimbursment

Chronic hypertension

1.5

8.0

269

1883

NA1DG

NOMESCO Finland

Cervical spine very extensive MRI examination with high intensity magnet

22.1

8.0

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.8

8.0

124

718

GX2D5

NOMESCO Finland

Sleep oximetry

6.3

8.0

WZA00

NOMESCO Finland

Concise certificate

1.8

8.0

117

666

C03AA03

ATC

hydrochlorothiazide; oral

1.9

8.0

506

SPAT1210

SPAT

Application of cast or individual aid

2.2

8.0

301

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

8.0

268

1877

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.8

8.0

119

682

SPAT1141

SPAT

Excision of skin or mucous membrane lesion

2.2

8.0

308

TEA00

NOMESCO Finland

Biopsy of lip

4.3

7.9

M77.1

ICD-10 Finland

Lateral epicondylitis

1.7

7.9

140

842

K07.68

ICD-10 Finland

Other disorders of the jaw joint

4.6

7.9

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.8

7.9

116

662

WVA20, ,

SPAT

2.6

7.9

166

A02BA03

ATC

famotidine; systemic

2.6

7.9

166

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

3.1

7.9

105

SPAT1283

SPAT

Restricted health certificate

1.4

7.9

372

2779

N03AX09

ATC

lamotrigine; oral

1.9

7.8

481

L40.8

ICD-10 Finland

Other psoriasis

6.1

7.8

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.8

7.8

114

648

S04

ICPC

Lump/swelling localized

1.6

7.8

168

1063

SPAT1370

SPAT

Other health check-up

2.2

7.8

297

D02

ICPC

Abdominal pain epigastric

1.9

7.8

525

N02CC04

ATC

rizatriptan; oral

1.8

7.8

118

679

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.6

7.8

167

3029

Kela drug reimbursment

Upadacitinib

9.4

7.8

N01

ICPC

Headache

1.6

7.8

192

1257

SPAT1262

SPAT

Handing over of treatment supplies

1.5

7.8

236

1618

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

2.0

7.8

399

R31

ICD-10 Finland

Unspecified haematuria

1.8

7.7

111

629

M13

ICD-10 Finland

Other arthritis

45.1

7.7

NAG41

NOMESCO Finland

Anterior fusion of cervical spine with fixation

45.1

7.7

7290A

ICD-9 Finland

Other disorders of soft tissues, Rheumatism, unspecified and fibrositis

15.1

7.7

R2110

NOMESCO Finland

Giving the first information

1.7

7.7

132

787

R35

ICD-10 Finland

Polyuria

2.0

7.7

400

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.7

7.7

129

765

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.7

7.7

134

804

H92.0

ICD-10 Finland

Otalgia

1.8

7.6

109

617

SPAT1104

SPAT

Monitoring of emergency patient

1.9

7.6

465

G55.1*M51.9

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)

18.4

7.6

K02

ICD-10 Finland

Dental caries

1.7

7.6

133

798

D82

ICPC

Teeth/gum disease

1.3

7.6

723

6011

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

8.9

7.5

M89.0

ICD-10 Finland

Algoneurodystrophy

6.2

7.5

L04

ICPC

Chest symptom/complaint

1.9

7.5

531

C10AX09

ATC

ezetimibe; oral

1.6

7.5

187

1226

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

2.1

7.5

322

K92.1

ICD-10 Finland

Melaena

2.2

7.5

289

A01AB04

ATC

amphotericin B; local oral

2.3

7.5

257

E000003, ,

ATC

2.0

7.5

398

A11

ICPC

Chest pain NOS

1.8

7.5

104

584

NA3BG, ,

SPAT

2.2

7.4

290

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.5

7.4

211

1427

J01XC01

ATC

fusidic acid; systemic

3.3

7.4

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.8

7.4

108

616

N41.1

ICD-10 Finland

Chronic prostatitis

3.0

7.4

104

T78.4

ICD-10 Finland

Allergy, unspecified

2.0

7.4

414

J01MA06

ATC

norfloxacin; oral

1.5

7.4

201

1347

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

7.3

469

3678

NHG22

NOMESCO Finland

Fusion of subtalar joint

8.4

7.3

S01

ICPC

Pain/tenderness of skin

2.1

7.3

299

WX723

NOMESCO Finland

CPAP therapy

2.0

7.3

353

72899

ICD-8 Finland

Vertebrogenic pain syndrome, Other and unspecified

+∞

7.3

NAG65

NOMESCO Finland

Anterior and posterior fusion of lumbar spine

+∞

7.3

7249X

ICD-9 Finland

Other and unspecified disorders of back, Other unspecified back disorders

+∞

7.3

NJ3CG

NOMESCO Finland

Extensive MRI examination of extremities with median high magnet

10.9

7.3

ZYY98

NOMESCO Finland

Missed treatment contact, no notification given by patient

10.9

7.3

RK210, ,

NOMESCO Finland

9.4

7.3

A02BA04

ATC

nizatidine; systemic

1.9

7.3

458

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.9

7.3

516

Q79.6

ICD-10 Finland

Ehlers-Danlos syndrome

15.8

7.2

N76.0

ICD-10 Finland

Acute vaginitis

1.7

7.2

132

802

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.1

7.2

294

S22.3

ICD-10 Finland

Fracture of rib

1.8

7.2

539

M03BX01

ATC

baclofen; systemic

3.0

7.2

100

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

7.2

1347

12187

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

2.5

7.2

174

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.6

7.2

146

912

N41.0

ICD-10 Finland

Acute prostatitis

3.1

7.2

1222

FHL

Arthroscopy and synovial surgery

3.9

7.2

L04AC21

ATC

bimekizumab; systemic

30.1

7.1

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.4

7.1

205

SPAT1251

SPAT

Organisation of medication

2.4

7.1

205

U07

ICPC

Urine symptom/complaint other

1.9

7.1

504

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

2.7

7.1

145

C05AA08

ATC

fluocortolone; rectal, topical

1.5

7.1

198

1331

O20.0

ICD-10 Finland

Threatened abortion

2.3

7.1

224

G44.0

ICD-10 Finland

Cluster headache syndrome

3.2

7.1

E66.9

ICD-10 Finland

Obesity, unspecified

2.1

7.1

309

ZZH40

NOMESCO Finland

Substitute of bone

6.6

7.1

H30.2

ICD-10 Finland

Posterior cyclitis

7.9

7.1

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

7.1

166

1074

R06AX13

ATC

loratadine; oral

1.4

7.1

291

2118

C10AA04

ATC

fluvastatin; oral

1.9

7.1

420

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.9

7.1

499

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.2

7.0

277

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

7.0

271

1948

NHF15

NOMESCO Finland

Synovectomy of ankle, arthroscopic

10.1

7.0

71490

ICD-8 Finland

Other specified forms of arthritis, Arthritis postinfectiosa NUD

10.1

7.0

M02AA15

ATC

diclofenac; topical

1.8

7.0

104

595

SPAT1101

SPAT

Orthostatic test

2.5

7.0

170

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.0

7.0

379

R96

ICPC

Asthma

1.7

7.0

130

793

E000007, ,

ATC

1.8

7.0

544

R06AX22

ATC

ebastine; oral

1.4

7.0

317

2347

L05

ICPC

Flank/axilla symptom/complaint

1.9

7.0

465

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

4.4

7.0

H40.0

ICD-10 Finland

Glaucoma suspect

1.8

6.9

108

627

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.0

6.9

367

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.0

6.9

374

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.5

6.9

215

1481

Y88

ICD-10 Finland

Sequelae with surgical and medical care as external cause

5.5

6.9

NH3CG

NOMESCO Finland

Extensive MRI of foot

5.5

6.9

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.6

6.9

168

1097

M16.6

ICD-10 Finland

Other secondary coxarthrosis, bilateral

13.8

6.9

78551

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD

2.3

6.9

215

P76

ICPC

Depressive disorder

1.7

6.9

118

705

L87

ICPC

Bursitis/tendinitis/synovitis NOS

3.2

6.8

SPAT1043

SPAT

Audiometry

1.7

6.8

110

645

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.6

6.8

168

1099

SPAT1211

SPAT

Application of soft bandage

1.7

6.8

116

691

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.7

6.8

122

737

I49.1

ICD-10 Finland

Atrial premature depolarization

2.2

6.8

235

P03

ICPC

Feeling depressed

1.6

6.8

178

1181

R25.2

ICD-10 Finland

Cramp and spasm

2.8

6.8

120

NH3AE

NOMESCO Finland

Feet ultrasound examination

11.0

6.8

ZXM20

NOMESCO Finland

Intraoperative use of computerised tomography

11.0

6.8

R01AC02

ATC

levocabastine; nasal

2.2

6.8

268

L04AF03

ATC

upadacitinib; oral

9.3

6.8

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

3.0

6.8

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.7

6.8

111

655

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.7

6.7

126

770

M84.3

ICD-10 Finland

Stress fracture, not elsewhere classified

2.8

6.7

115

Z56.5

ICD-10 Finland

Uncongenial work

16.7

6.7

R06.2

ICD-10 Finland

Wheezing

2.0

6.7

364

H93.1

ICD-10 Finland

Tinnitus

1.8

6.7

103

596

XF402

NOMESCO Finland

ECG with work load test

1.7

6.7

120

725

OAB72, ,

SPAT

3.2

6.7

M17.3

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019198) Lymphocytes [#/volume] in Blood

1722

8029

7.44

307.65

11.3

5.7

2.05

1.94

e9/l

2.97

1657

7198

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

448

480

11.60

307.65

1.5

1.6

0.11

0.62

iu/ml

0.77

108

(3006315) Basophils [#/volume] in Blood

1712

7744

7.64

307.65

11.2

5.7

0.04

e9/l

2.86

1632

6772

(3001604) Monocytes [#/volume] in Blood

1712

7739

7.64

307.65

11.2

5.7

0.56

0.55

e9/l

1.03

1633

6770

(3013115) Eosinophils [#/volume] in Blood

1729

8038

7.60

307.65

11.4

6.0

0.18

e9/l

0.45

1657

7150

(40760892) CBC W Ordered Manual Differential panel - Blood

1683

7282

7.68

307.65

11.7

6.2

—

(3008898) HLA-B27 [Presence]

406

548

8.95

293.62

1.1

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1753

8993

6.83

277.36

13.2

9.2

3.89

3.95

e9/l

0.67

1668

7903

(3022096) Basophils/100 leukocytes in Blood

1480

7075

4.72

242.25

11.7

5.9

0.73

0.68

2.38

1445

6636

(3013707) Erythrocyte sedimentation rate by Westergren method

1931

11454

9.81

240.30

9.9

3.4

11.56

10.38

mm/h

3.87

1890

10661

(3037522) Nuclear Ab [Titer] in Serum

739

2145

4.78

237.90

1.5

1.3

430.34

571.03

titre

1.50

174

428

(3019069) Monocytes/100 leukocytes in Blood

1511

7395

4.75

237.89

11.9

6.1

8.45

8.34

0.87

1478

6978

(3006504) Eosinophils/100 leukocytes in Blood

1502

7337

4.70

236.59

11.6

5.8

2.69

2.81

1.38

1470

6914

(3002030) Lymphocytes/100 leukocytes in Blood

1519

7708

4.53

221.06

11.7

5.8

30.60

28.95

9.02

1487

7297

(3018010) Neutrophils/100 leukocytes in Blood

1501

7596

4.45

218.13

11.1

5.7

55.45

56.59

3.87

1468

7187

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1874

11556

6.92

201.41

10.9

6.9

72.41

75.79

u/l

4.06

1839

10917

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

130

27.65

189.88

1.5

2.3

9.47

10.01

mg/l

0.26

(3021601) Nitrite [Presence] in Urine by Test strip

1414

7487

3.74

177.25

6.6

4.1

0.00

estimate

0.32

382

1423

(3009261) Glucose [Presence] in Urine by Test strip

1420

7541

3.74

177.13

5.3

3.0

0.00

0.01

estimate

1.32

368

1359

(3035350) Ketones [Presence] in Urine by Test strip

1411

7463

3.73

177.13

5.3

2.9

0.00

estimate

0.80

392

1471

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

227

282

8.91

173.01

4.0

3.7

56.43

56.27

0.06

227

282

(3037467) Urinalysis macro (dipstick) panel - Urine

1701

10527

4.28

160.36

6.2

3.6

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

688

2442

3.71

159.27

1.3

1.2

7.81

12.30

u/ml

1.02

301

1035

(3025159) Blasts/100 leukocytes in Blood

405

1080

4.41

138.86

5.5

4.5

0.02

0.76

1.00

266

(3015736) pH of Urine

1163

6044

3.08

138.06

4.6

2.8

5.91

0.02

659

(3017181) Myelocytes/100 leukocytes in Blood

427

1193

4.24

137.52

5.3

4.4

0.50

1.04

3.92

112

374

(3002179) Metamyelocytes/100 leukocytes in Blood

405

1096

4.34

136.03

4.7

4.2

0.34

0.67

1.88

325

(3029937) Albumin [Presence] in Urine by Test strip

857

3817

3.11

132.86

6.1

3.2

0.00

estimate

1.08

373

1381

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

675

2623

3.32

132.02

1.3

1.2

29.23

28.83

iu/ml

0.02

228

852

(3021440) Promyelocytes/100 leukocytes in Blood

409

1144

4.20

131.13

5.5

4.4

0.06

0.13

1.03

326

(3021589) Normoblasts [#/volume] in Blood

1274

7109

3.02

130.36

14.4

8.2

0.00

e9/l

0.25

1142

5822

(3011397) Hemoglobin [Presence] in Urine by Test strip

747

3154

3.13

125.99

5.0

2.9

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

20.00

118.63

2.3

2.2

80.52

159.92

au/ml

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

18.25

118.59

2.4

2.9

6.50

9.16

mg/l

1.86

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1095

5862

2.82

116.98

5.6

3.0

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

185

294

6.81

112.75

1.5

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

260

578

4.99

110.80

1.4

1.2

1.56

0.95

u/ml

0.28

(3021788) Differential panel - Synovial fluid

148

201

7.85

103.90

1.9

1.6

—

(3000475) Leukocytes [#/volume] in Synovial fluid

166

264

6.74

100.93

1.8

1.7

10413.00

14051.96

e6/l

0.45

126

193

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

906

4702

2.63

98.38

3.9

2.8

—

(3019150) Specific gravity of Urine by Refractometry

666

3007

2.78

94.99

5.8

3.2

1.02

kg/l

0.61

449

(3018095) Leukocytes [#/volume] in Urine

917

4865

2.57

94.11

3.8

3.1

59.71

89.51

e6/l

0.81

647

3218

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1095

6331

2.53

93.26

2.7

2.1

76.56

74.99

nmol/l

1.13

1040

5861

(3048689) Calprotectin [Mass/mass] in Stool

510

2016

3.02

92.92

2.9

2.4

118.35

116.21

ug/g

0.06

427

1640

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

109

125

9.14

87.71

1.8

1.7

57.51

58.78

0.10

(3017143) Hepatitis C virus Ab [Presence] in Serum

541

2285

2.84

86.63

1.4

1.6

—

(40758558) Short blood count panel - Blood

762

3851

2.54

84.76

8.2

6.9

—

(3044941) Cell count panel - Synovial fluid

123

173

7.49

83.56

1.6

1.4

—

(40761535) Cells panel - Urine sediment

304

934

3.64

83.17

5.6

2.9

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

202

470

4.65

80.78

1.7

1.9

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

9.78

79.09

1.7

1.5

42.58

33.41

1.00

(3000850) Epithelial cells [#/volume] in Urine

580

2661

2.63

77.93

2.6

2.3

4.77

7.34

e6/l

3.83

528

2366

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2031

16864

7.79

77.08

21.4

10.3

15.16

21.85

mg/l

29.92

1825

12744

(3018418) pH of Serum or Plasma

721

3760

2.40

72.74

3.5

3.9

7.40

0.53

171

757

(3021879) Hepatitis B virus core Ab [Presence] in Serum

390

1515

2.93

71.71

1.3

1.5

—

(3005719) IgG [Mass/volume] in Serum or Plasma

320

1138

3.14

68.59

2.7

10.66

10.65

g/l

0.02

293

1048

(3024561) Albumin [Mass/volume] in Serum or Plasma

962

5776

2.23

68.46

4.5

4.8

36.59

36.34

g/l

0.75

914

5400

(3030467) Casts [#/volume] in Urine by Automated count

675

3572

2.31

64.43

3.0

2.7

0.21

0.41

e6/l

3.64

552

2626

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1029

6492

2.15

62.99

5.6

6.2

1.22

1.21

mmol/l

0.83

851

5514

(36304419) Bacteria [Presence] in Urine

668

3559

2.29

62.39

2.8

2.6

—

(3026493) Urate [Moles/volume] in Serum or Plasma

684

3687

2.27

62.07

2.2

2.3

3048.88

4163.73

umol/l

0.37

607

3363

(3041096) Erythrocytes [Presence] in Urine by Automated

772

4418

2.18

60.01

4.5

2.7

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

12.62

60.00

1.6

1.3

4.23

1.30

—

(3002582) Erythrocytes [#/volume] in Urine

709

3958

2.20

58.35

3.1

2.7

97.70

126.83

e6/l

0.14

588

2956

(3002385) Erythrocyte distribution width [Ratio]

1845

15046

2.90

56.98

22.3

12.8

13.94

14.48

10.00

1833

14756

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

664

3652

2.20

56.38

2.3

2.0

140.31

297.78

u/l

2.60

629

3436

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

920

5789

2.05

54.26

5.3

5.5

1.21

mmol/l

0.08

865

5316

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

610

3362

2.15

50.60

2.6

2.1

2.88

2.85

mg/l

0.13

538

2879

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

731

4315

2.07

50.53

2.5

2.4

56.25

60.52

u/l

0.64

671

4007

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

621

3451

2.14

50.39

1.6

—

(4034850) Laboratory test

161

457

3.73

48.81

8.4

6.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

242

894

2.93

47.75

1.7

1.9

1.33

1.52

g/l

0.74

229

833

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1071

7362

1.93

46.64

5.0

6.1

9.81

11.09

umol/l

2.10

1010

7000

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1095

7594

1.93

46.31

3.3

2.7

109.87

100.15

ug/l

0.60

1036

7146

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2038

18122

5.66

45.05

20.3

11.6

71.88

72.54

umol/l

0.44

2038

18117

(3031040) Bacteria [#/volume] in Urine by Automated count

1326

9855

1.94

44.87

4.5

3.5

696.67

1630.72

e6/l

0.45

119

(3036071) Salmonella sp Ab [Titer] in Serum

9.15

41.69

1.2

1.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

139

397

3.68

41.68

1.1

1.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

409

2068

2.22

41.18

2.3

2.4

0.98

1.25

e6/l

0.48

276

1128

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2039

18333

5.27

40.04

20.4

8.5

27.17

26.56

u/l

0.82

2019

17756

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

178

611

3.09

39.80

1.3

—

(3022948) Iron [Moles/volume] in Serum or Plasma

402

2057

2.18

39.10

2.4

2.3

13.15

14.05

umol/l

1.55

369

1923

(40761536) Microorganisms panel - Urine sediment

296

1345

2.40

38.12

4.7

3.2

—

(3022145) Colonoscopy Study observation

333

1605

2.28

37.38

1.5

1.3

—

(3026782) Osmolality of Urine

470

2603

2.04

36.88

3.1

2.5

543.73

548.36

mosm/kgh2o

0.16

417

2219

(3004588) Protein electrophoresis panel - Serum or Plasma

186

685

2.88

36.65

1.9

2.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

244

1045

2.51

35.65

2.4

2.3

22.86

22.03

au/ml

0.06

115

(3010144) Erythrocytes [#/volume] in Synovial fluid

105

6.05

35.20

1.5

1.4

3589.44

48087.28

e6/l

0.90

(3007164) IgA [Mass/volume] in Serum or Plasma

556

3330

1.91

34.46

1.6

1.4

2.42

2.29

g/l

0.95

401

2178

(3042936) Bacteria identified in Isolate by Culture

363

1868

2.14

34.44

2.3

1.9

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

211

4.31

33.58

1.3

1.4

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

363

1887

2.12

33.48

2.3

2.41

2.40

g/l

0.12

332

1758

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

224

953

2.51

33.11

1.3

45.87

50.74

au/ml

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1105

8217

1.73

32.46

4.6

4.2

6.38

6.56

mmol/l

2.52

1041

7570

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

338

1729

2.14

32.43

2.4

22.51

23.97

1.10

280

1504

(3024980) IgG subclass 4 [Mass/volume] in Serum

235

4.05

32.28

1.7

1.9

0.46

0.80

g/l

2.79

179

(4062490) Immunoglobulin typing, IgG

137

5.10

32.05

1.5

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

284

1362

2.26

31.98

2.3

2.0

340.93

375.66

nmol/l

2.28

267

1268

(3023103) Potassium [Moles/volume] in Serum or Plasma

1905

16822

2.47

31.81

15.0

11.2

3.92

3.94

mmol/l

1.06

1873

16270

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

202

834

2.57

31.76

1.8

1.6

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1897

16744

2.41

31.29

15.0

11.1

139.51

139.70

mmol/l

3.27

1867

16237

(3020630) Protein [Mass/volume] in Serum or Plasma

205

859

2.54

31.24

2.0

2.7

68.37

66.82

g/l

2.20

185

807

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

707

4690

1.77

30.80

3.5

2.7

134.79

45.95

ng/l

0.36

412

2562

(3022217) INR in Platelet poor plasma by Coagulation assay

822

5699

1.73

30.56

10.8

10.7

1.17

1.18

inr

0.21

330

1811

(46235355) HIV 1 and 2 tests - Meaningful Use set

649

4220

1.78

30.16

1.8

1.9

—

(3024263) Appearance of Synovial fluid

7.35

30.15

1.5

1.6

—

(3023368) Bacteria identified in Blood by Culture

523

3194

1.85

29.88

4.9

4.0

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

138

4.91

29.81

1.6

1.4

0.38

0.41

g/l

0.28

(3028192) IgG subclass 2 [Mass/volume] in Serum

138

4.91

29.81

1.6

1.4

3.00

2.89

g/l

0.20

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

134

462

3.03

29.63

1.9

1.8

1.20

1.18

g/l

0.32

129

433

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

600

3831

1.79

29.56

1.3

1.64

1.66

u/ml

0.01

186

1082

(3027135) IgG subclass 1 [Mass/volume] in Serum

139

4.87

29.56

1.6

1.4

6.25

6.94

g/l

0.68

(3044889) 12 lead EKG panel

1333

10673

1.69

27.70

3.4

3.0

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

114

373

3.17

27.56

2.0

1.5

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

685

4648

1.70

26.70

2.7

3.4

2.34

2.35

mmol/l

0.74

635

4230

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1562

13144

1.74

26.06

4.2

3.9

14.69

14.50

pmol/l

2.59

1459

12180

(3021960) Folate [Moles/volume] in Serum or Plasma

454

2755

1.83

26.03

1.5

1.4

20.73

20.81

nmol/l

0.03

410

2398

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1810

15953

1.99

25.63

15.7

9.5

91.06

88.16

ml/min/173m2

7.92

1629

13036

(3019309) Folate [Moles/volume] in Red Blood Cells

361

2054

1.92

25.27

1.8

1.6

1387.46

1138.88

nmol/l

5.35

283

1587

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

767

5436

1.65

24.91

3.5

3.1

32.92

31.25

u/l

0.39

725

5177

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

744

5271

1.64

23.98

2.0

1.8

96.53

97.32

pmol/l

0.18

418

2855

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

518

3341

1.73

23.84

1.8

1.6

0.92

1.01

mg/l

0.33

393

2453

(40761511) CBC panel - Blood by Automated count

1977

18133

2.62

23.75

17.9

9.7

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

331

1870

1.91

23.56

1.8

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

388

2318

1.83

23.13

3.1

3.0

507.12

600.03

ng/l

0.13

238

1519

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

115

419

2.85

23.02

2.2

0.99

2.08

ug/l

0.76

106

379

(40768797) Stomach Pathology biopsy report

330

1883

1.89

22.73

1.3

1.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

121

458

2.74

22.54

1.3

85.83

84.57

titre

0.02

(3027945) Reticulocytes/100 erythrocytes in Blood

240

1235

2.07

22.24

2.3

2.9

1.84

1.74

0.74

223

1117

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

380

2283

1.81

22.16

2.5

2.9

2.43

mmol/l

0.57

337

2010

(3025941) Bacteria identified in Stool by Culture

193

916

2.22

22.02

1.4

1.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

238

1226

2.06

21.99

1.7

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

6.06

21.24

1.3

1.6

5.32

6.26

u/l

0.52

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

113

427

2.74

21.12

1.5

1.2

14.12

47.52

u/ml

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

233

1214

2.03

20.83

1.7

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

150

658

2.38

20.57

1.8

2.2

39.38

39.10

u/l

0.07

135

599

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

334

2.90

19.71

1.6

1.2

27.05

35.87

u/ml

0.25

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

441

2851

1.69

19.64

1.8

1.6

37173199.39

39633072.49

pmol/l

0.03

382

2450

(3026008) Bacteria identified in Urine by Culture

561

3865

1.62

19.44

3.1

2.4

—

(3023520) Reticulocytes [#/volume] in Blood

177

866

2.14

18.66

2.2

2.9

75.18

72.46

e9/l

0.42

136

660

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

206

1069

2.03

18.57

4.3

3.4

1.22

1.23

mmol/l

0.50

188

922

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1746

15602

1.72

18.46

4.9

4.4

1.67

2.10

mu/l

2.27

1655

14569

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

562

3916

1.59

18.42

1.9

1.5

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

101

390

2.67

18.11

1.7

1.9

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

101

390

2.67

18.11

1.5

1.2

4.21

9.88

u/ml

0.77

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

245

1367

1.90

17.86

3.4

2.7

—

(3017732) Neutrophils [#/volume] in Blood

206

1093

1.98

17.42

3.1

2.7

4.27

4.78

e9/l

0.49

178

949

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

389

2.62

17.16

1.5

1.2

2.24

3.45

u/ml

0.41

(3000494) Fungus identified in Specimen by Culture

296

1774

1.78

17.10

1.4

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

110

4.16

16.82

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

110

4.16

16.82

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

110

4.16

16.82

1.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

238

1342

1.87

16.76

2.3

4.7

226.14

242.28

u/l

1.22

223

1283

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

424

2819

1.63

16.65

2.7

2.9

1169.87

1129.49

ng/l

0.05

363

2342

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

112

4.08

16.43

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

112

4.08

16.43

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

112

4.08

16.43

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

181

3.33

15.91

1.5

1.3

9.47

56.29

u/ml

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

328

2.69

15.83

3.1

2.9

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

105

442

2.45

15.78

1.9

1.7

160.00

423.33

titre

0.73

(3009542) Hematocrit [Volume Fraction] of Blood

2055

19612

3.57

15.70

30.3

15.4

40.34

40.80

1.02

1935

18592

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

291

2.78

15.54

1.4

1.2

3.56

1.25

u/ml

—

(3007461) Platelets [#/volume] in Blood

2055

19640

3.49

15.10

30.4

15.4

272.40

258.51

e9/l

18.43

2047

19162

(3007853) Bacteria identified in Skin by Aerobe culture

271

1645

1.74

14.88

2.0

1.6

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

6.83

14.87

1.3

—

(3020891) Body temperature

394

2.48

14.75

5.3

4.4

—

(3024731) MCV [Entitic volume]

2055

19656

3.44

14.75

30.2

15.3

91.13

90.31

13.88

2050

19393

(3035941) MCH [Entitic mass]

2055

19657

3.44

14.73

30.2

15.3

30.26

30.14

2.31

2049

19391

(3010813) Leukocytes [#/volume] in Blood

2055

19659

3.43

14.69

30.4

15.4

6.92

6.59

e9/l

7.68

2045

19137

(3026361) Erythrocytes [#/volume] in Blood

2055

19662

3.42

14.62

30.4

15.3

4.48

4.55

e12/l

11.32

2047

19148

(3000963) Hemoglobin [Mass/volume] in Blood

2055

19670

3.40

14.45

30.5

15.4

134.91

136.63

g/l

8.05

2050

19398

(3005322) IgE [Units/volume] in Serum or Plasma

194

1079

1.88

14.21

1.3

204.08

204.12

u/ml

0.00

185

997

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

893

7152

1.43

14.03

2.6

2.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

213

2.97

13.87

1.5

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

338

2.52

13.42

2.0

2.1

0.49

0.83

g/l

0.63

301

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

245

2.79

13.40

1.3

—

60.00

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

307

1980

1.65

13.38

2.6

2.5

3.31

3.32

e6/l

0.00

179

1036

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

193

1095

1.84

13.27

2.6

2.1

69.06

72.64

ml/min/173m2

0.44

402

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

5.77

13.21

1.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

307

2.57

13.01

1.7

2.0

0.00

0.01

g/l

0.80

285

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1489

13213

1.44

12.37

3.6

3.3

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

126

634

2.05

12.34

2.7

2.6

0.24

0.25

e6/l

0.06

118

605

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

287

2.56

12.19

1.3

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

114

557

2.11

12.08

1.7

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

225

2.76

12.03

1.1

1.3

—

(40768443) Skin Pathology biopsy report

116

574

2.08

11.89

1.3

1.2

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

444

2.19

11.28

4.7

3.4

52.08

49.69

0.40

436

(3019060) Gas panel - Arterial blood

129

679

1.96

11.15

5.2

5.9

—

(40767503) Oxygen content in Capillary blood by calculation

229

2.67

11.11

2.2

2.3

16.99

16.84

0.10

114

(3002032) Base excess in Venous blood by calculation

172

1002

1.78

10.83

3.7

3.6

2.13

1.86

mmol/l

0.46

150

823

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

287

2.42

10.25

1.8

2.0

0.00

g/l

-0.00

265

(3037756) Immunofixation for Serum or Plasma

204

2.69

10.22

1.5

1.8

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

431

2.14

10.08

2.0

2.2

9.73

11.76

mg/l

1.33

403

(3027801) Oxygen [Partial pressure] in Arterial blood

202

1258

1.67

10.01

7.2

8.3

12.14

13.13

kpa

2.28

197

1206

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

202

1258

1.67

10.01

7.2

8.3

5.05

5.09

kpa

0.27

197

1207

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

285

2.40

9.94

1.8

2.0

0.00

g/l

-0.00

264

(3004809) Band form neutrophils/100 leukocytes in Blood

190

2.73

9.92

3.2

3.0

1.35

1.31

0.02

175

(3018677) aPTT in Platelet poor plasma by Coagulation assay

288

1965

1.54

9.75

1.9

2.1

29.49

29.54

0.06

277

1903

(3024354) Oxygen [Partial pressure] in Venous blood

142

809

1.81

9.64

3.5

2.7

4.80

4.76

kpa

0.04

142

773

(3012501) Base excess in Blood by calculation

278

2.38

9.54

2.5

3.5

2.60

2.45

mmol/l

0.19

177

(3009871) Measles virus Ab [Titer] in Serum

4.14

9.44

1.7

1.6

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

115

617

1.91

9.43

2.5

2.2

—

(3033658) Prothrombin time (PT) actual/Normal

477

3617

1.41

9.40

3.7

3.6

95.72

94.50

0.56

462

3531

(3029075) Extractable nuclear Ab panel - Serum

5.17

9.36

1.2

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

338

2.23

9.34

1.5

1.4

277.81

294.99

ug/g

0.27

189

(40760888) Immunoglobulin light chains.free panel - Serum

214

2.56

9.32

2.5

3.7

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1755

0.51

9.27

3.3

3.8

33.72

31.88

0.72

1274

(3003396) Base excess in Arterial blood by calculation

199

1263

1.64

9.15

7.3

8.3

1.22

1.07

mmol/l

0.24

160

1013

(3026389) Candida sp identified in Specimen by Organism specific culture

193

2.63

9.11

1.7

1.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

491

2.00

9.05

1.8

2.0

1.45

1.48

g/l

0.14

426

(3034860) Kappa light chains.free [Mass/volume] in Serum

281

2.32

8.88

2.5

3.4

30.53

73.64

mg/l

1.14

220

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

256

2.38

8.88

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

275

2.33

8.86

2.4

3.4

1.13

1.15

ratio

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

522

4068

1.38

8.65

1.7

1.6

1.50

1.41

mmol/l

0.87

431

3484

(3012095) Magnesium [Moles/volume] in Serum or Plasma

299

2110

1.49

8.58

2.7

3.7

0.82

mmol/l

0.46

284

2000

(3003458) Phosphate [Moles/volume] in Serum or Plasma

239

1610

1.55

8.54

4.9

6.2

1.05

1.04

mmol/l

0.48

222

1518

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

245

1661

1.54

8.51

2.1

2.7

5.45

7.67

umol/l

2.34

205

1450

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1726

16064

1.42

8.48

4.0

3.7

5.75

5.76

mmol/l

0.23

1612

14911

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

281

2.28

8.44

2.5

3.4

22.66

58.70

mg/l

0.96

223

(3045414) Leukocytes [Presence] in Urine

112

619

1.86

8.41

1.9

1.7

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1610

14818

1.37

8.39

5.0

4.6

37.92

38.63

mmol/mol

2.65

1534

13934

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

316

2.19

8.27

1.3

3.55

3.68

mmol/l

0.57

301

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

352

2583

1.44

8.23

1.8

1.9

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

140

2.82

8.18

1.4

2.2

32.00

32.37

0.16

140

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

4.03

8.07

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

165

1032

1.65

8.05

2.2

12.81

12.84

nmol/l

0.02

155

957

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

197

1289

1.58

8.00

1.6

1.7

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

104

3.11

7.99

1.3

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

398

2.02

7.81

2.4

3.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

4.53

7.65

1.1

—

(3045424) Erythrocytes [Presence] in Urine

261

2.26

7.64

1.6

1.4

—

(1616796) Gas panel - Central venous blood

251

2.26

7.46

2.2

3.5

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

3.11

7.29

1.3

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

3.11

7.29

1.3

1.2

—

(3003338) MCHC [Mass/volume]

1661

15465

1.36

7.27

24.8

13.0

331.91

332.89

g/l

4.58

1654

15334

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

320

2.10

7.25

1.3

1.4

16.17

27.63

e6/l

0.31

250

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

320

2.10

7.25

1.3

1.5

360.71

938.66

e6/l

0.50

259

(42529406) Shigella sp [Presence] in Stool by Culture

453

1.91

7.18

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

448

1.91

7.08

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

135

830

1.67

7.06

2.3

2.8

78.91

174.87

ng/l

5.98

126

733

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

152

2.60

7.04

1.3

—

nmol/l

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

444

1.91

6.94

1.2

1.1

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

188

1258

1.54

6.93

2.5

2.2

0.22

g/l

0.05

173

1185

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

137

850

1.65

6.92

3.1

4.0

84.16

81.56

ng/l

0.14

117

760

(3023323) Follitropin [Units/volume] in Serum or Plasma

179

1189

1.55

6.82

1.3

24.98

27.81

iu/l

0.54

149

1025

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

161

2.51

6.77

1.3

1.4

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

3.65

6.75

1.1

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

377

2900

1.37

6.60

1.9

2.0

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

278

2.12

6.59

1.2

1.4

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

365

1.95

6.34

1.3

488.92

502.48

mg/l

0.08

352

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

3.60

6.31

1.2

1.1

—

(3022621) pH of Urine by Test strip

141

903

1.60

6.29

3.9

2.4

—

(3047181) Lactate [Moles/volume] in Blood

383

1.91

6.16

5.6

7.0

1.49

1.24

mmol/l

0.60

334

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

225

2.16

5.81

1.4

1.6

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

199

1399

1.47

5.80

1.2

64.32

147.36

iu/ml

3.81

545

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

108

2.71

5.76

1.2

2.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

2.93

5.73

1.1

1.43

1.08

u/l

—

(3036670) Protein [Mass/volume] in Synovial fluid

5.59

5.68

1.3

1.2

36.91

41.22

g/l

—

(3000991) Gas panel - Venous blood

144

951

1.55

5.66

7.3

8.8

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

131

847

1.58

5.64

2.2

2.0

10.55

7.93

ug/l

0.17

115

752

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

164

2.34

5.59

1.4

1.7

—

(3009508) Creatinine [Moles/volume] in Urine

512

4205

1.29

5.58

2.6

3.3

7.43

7.89

mmol/l

1.32

444

3671

(3000012) Reticulocyte production index

140

2.45

5.54

1.9

2.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

140

2.45

5.54

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

134

2.49

5.54

1.2

1.9

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

198

2.20

5.45

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

328

1.92

5.43

1.5

1.7

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

239

2.08

5.38

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

130

2.48

5.37

1.2

26.33

45.15

mg/l

3.69

105

(3047007) Chlamydophila sp Ab [Presence] in Serum

260

2.03

5.35

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

2.80

5.31

1.2

1.7

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

11.29

5.29

1.0

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

303

1.94

5.28

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

570

1.68

5.25

1.3

1.4

13.58

9.81

u/l

1.29

468

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

227

1667

1.41

5.23

1.9

1.8

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

290

1.96

5.23

1.2

9.90

3.74

u/ml

0.48

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

502

1.72

5.23

1.1

4.58

5.02

u/ml

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

120

2.52

5.21

1.1

1.2

1.06

1.04

ratio

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

458

1.75

5.18

1.2

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

171

2.24

5.11

1.2

1.7

—

(3012516) Albumin [Mass/volume] in Urine

449

3664

1.29

5.09

2.8

3.4

1241.19

333.05

mg/l

1.52

278

2378

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

322

1.89

5.06

1.4

1.7

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

315

1.90

5.05

1.4

1.7

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

116

2.52

5.04

1.7

1.2

73.90

75.03

umol/l

0.15

116

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

388

1.80

5.03

2.0

2.3

254.05

475.01

ug/l

0.79

363

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

232

2.05

5.02

1.4

1.5

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

2.82

4.98

1.1

0.09

5.04

nmol/l

—

(40768804) Tissue Pathology biopsy report

765

6667

1.23

4.88

2.0

1.9

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

109

701

1.59

4.84

1.5

1.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

200

1459

1.41

4.80

7.5

5.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

144

2.31

4.78

1.3

1.5

—

(3005011) Chlamydia sp Ab [Titer] in Serum

5.23

4.77

1.4

1.5

—

(3017704) Immunofixation for Urine

3.18

4.76

1.7

1.6

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

102

2.57

4.72

1.7

1.6

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

3.51

4.61

1.1

1.3

—

(36660697) Celiac disease serology panel - Serum

184

1333

1.42

4.60

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

623

1.60

4.59

1.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

623

1.60

4.59

9.9

11.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

502

1.66

4.46

1.5

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

156

2.20

4.41

1.0

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

275

1.88

4.29

2.7

2.5

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

2.97

4.28

1.1

1.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

120

2.35

4.25

1.1

—

(21494755) Public health laboratory ask at order entry panel

202

2655

0.74

4.16

1.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

5.26

4.14

1.3

1.6

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

103

2.44

4.14

1.2

2.1

0.56

2.17

u/field

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

258

1.88

4.09

1.9

2.1

132.16

132.72

g/l

0.06

189

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

139

980

1.45

4.05

1.8

2.2

1623.86

6350.16

u/l

3.14

416

(3044640) Blood type and Crossmatch panel - Blood

547

4677

1.23

4.05

2.3

2.1

—

(3021901) Oxygen saturation in Capillary blood

183

2.04

4.00

2.4

2.8

—

(3012565) Volume of 24 hour Urine

2.61

3.97

1.2

2.5

2053.33

1851.89

0.39

(21494890) Protein electrophoresis panel - 24 hour Urine

2.49

3.96

1.6

2.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

460

3877

1.24

3.88

3.4

4.0

11.23

8.67

mg/mmol

0.51

278

2523

(3021387) Prolactin [Units/volume] in Serum or Plasma

122

847

1.47

3.86

1.8

1.7

325.72

300.87

mu/l

0.28

112

757

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

113

2.32

3.85

1.3

314.00

252.22

titre

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

174

2.03

3.75

1.4

1.5

—

(3049717) Cytology report of Urine Cyto stain

358

1.70

3.65

2.1

2.5

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

2.43

3.64

1.1

1.2

—

8.63

—

(3015183) Erythrocyte sedimentation rate

123

2.21

3.61

1.5

1.2

—

(3042631) Mycobacterium sp identified in Specimen

143

2.11

3.59

2.2

2.7

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

133

953

1.42

3.58

1.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

165

2186

0.73

3.58

1.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

220

1.88

3.55

1.3

1.9

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.46

3.55

1.1

1721.14

1388.85

miu/ml

0.67

(3044290) Cell count panel - Cerebral spinal fluid

311

1.72

3.44

1.2

1.5

—

(3004616) Nuclear Ab [Presence] in Serum

174

1.97

3.39

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

108

1520

0.69

3.39

1.3

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

154

1145

1.37

3.36

3.0

3.4

4.56

4.53

pmol/l

0.16

137

1031

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

277

1.75

3.31

1.2

1.1

15.32

10.97

au/ml

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

2.55

3.29

1.5

—

66.91

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

3.65

3.29

1.1

1.0

7.55

6.88

mg/g

0.08

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

362

1.65

3.27

1.1

1.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.87

3.19

1.0

2.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

359

1.63

3.12

1.1

1.2

254.39

275.86

u/ml

0.29

228

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

287

2350

1.26

3.12

1.6

1.7

1.45

1.37

1.23

253

2134

(3014051) Protein [Presence] in Urine by Test strip

314

1.67

3.08

3.1

2.1

—

(3023419) Bacteria identified in Sputum by Culture

146

2.00

3.05

1.5

2.5

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

537

1.51

3.05

3.7

3.8

24.70

24.05

mmol/l

1.29

523

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1302

12232

1.17

3.03

3.2

2.7

47.47

41.63

u/l

1.41

1235

11623

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

120

2.10

2.98

1.6

2.1

19.00

19.18

nmol/l

0.03

112

(3026480) Teichoate Ab [Titer] in Serum

10.02

2.98

1.0

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

639

1.46

2.98

1.7

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

134

998

1.37

2.93

1.6

1.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

382

1.59

2.90

1.1

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

343

1.62

2.90

1.1

1.4

104.12

105.57

u/ml

0.05

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

129

2.03

2.86

1.2

0.03

0.96

u/ml

1.79

(3003181) Sodium [Moles/volume] in Urine

157

1.92

2.85

1.7

1.4

66.56

64.42

mmol/l

0.08

132

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

298

1.66

2.85

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

294

2443

1.24

2.81

3.7

3.4

22.67

21.39

0.61

122

985

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

3.35

2.81

1.1

1.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

2.47

2.79

1.3

1.8

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

2.47

2.79

1.8

1.4

22.00

20.27

u/ml

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

180

1.85

2.78

1.2

—

(3000492) Spirometry study

215

1729

1.27

2.73

1.5

1.4

—

(44813793) Dust mix specific IgE antibody measurement

111

2.08

2.73

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

132

993

1.35

2.72

1.3

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

2.44

2.71

1.3

1.7

—

(3030313) Adrenal Ab [Titer] in Serum

6.01

2.70

1.0

1.1

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

171

0.29

2.67

11.2

13.2

674.60

867.20

nmol/l

—

164

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.80

2.64

1.8

1.6

7.54

8.38

ug/l

0.34

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.94

2.62

1.1

1.5

88.69

106.28

nmol/24h

0.35

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.19

2.57

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

7.15

2.55

1.0

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

104

763

1.38

2.53

1.3

265.02

233.34

miu/ml

0.39

388

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

362

3106

1.20

2.52

4.1

3.9

2.05

2.11

ug/l

0.05

334

2803

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

137

1.91

2.46

1.4

1.8

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

171

1356

1.28

2.45

2.1

2.2

38.03

75.44

u/l

0.55

137

1197

(3006922) Hepatitis E virus Ab [Presence] in Serum

124

1.95

2.40

1.1

1.0

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

160

1.82

2.39

1.7

1.6

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

160

1.82

2.39

1.7

1.6

—

(3044927) Protein electrophoresis panel - Urine

2.12

2.39

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.42

2.37

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

485

1.46

2.35

2.1

1.7

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

552

1.43

2.35

2.2

1.9

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2.19

2.31

1.2

1.7

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1775

17232

1.20

2.31

4.5

4.0

2.89

2.90

mmol/l

0.29

1686

16224

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

340

1.54

2.31

3.6

2.9

0.31

0.34

u/ml

0.32

189

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

119

1.94

2.30

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

656

0.63

2.29

1.5

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

373

1.52

2.29

1.1

1.4

—

17.32

—

(3006462) Nitrate [Presence] in Urine

2.56

2.27

5.1

2.0

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1758

17060

1.19

2.25

4.1

3.7

4.79

4.82

mmol/l

0.66

1681

16177

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.90

2.25

1.0

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

287

1.58

2.23

1.2

4.13

4.29

u/ml

0.04

122

(3014148) Varicella zoster virus Ab [Titer] in Serum

264

1.60

2.21

1.0

1.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

630

1.38

2.15

1.8

1.5

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

274

1.58

2.15

1.1

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

2.11

2.12

3.8

3.1

441.71

1167.54

u/ml

1.50

(3020650) Glucose [Presence] in Urine

2.46

2.10

2.0

1.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.46

2.10

1.0

1.4

104.71

91.85

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

398

3497

1.17

2.10

2.3

2.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.21

2.09

1.0

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

293

1.55

2.06

1.8

2.2

5.77

5.43

umol/l

0.07

216

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

110

1.92

2.05

1.6

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

636

0.65

2.02

1.4

—

(3023410) Appearance of Cerebral spinal fluid

162

1.74

2.02

1.2

1.6

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

162

1.74

2.02

1.1

1.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

3.08

2.01

1.5

1.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

264

1.56

1.98

1.3

1.7

—

(3005033) Fetal Nuchal fold Thickness US

632

0.66

1.97

1.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.36

1.95

1.0

1.1

98.57

91.68

—

(21494814) CD8 cells/100 lymphocytes in Specimen

2.20

1.94

1.0

2.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

109

844

1.31

1.93

1.4

—

(3000330) Specific gravity of Urine by Test strip

626

1.36

1.92

4.5

2.9

—

(3032057) Clostridioides difficile [Presence] in Stool

3.19

1.88

3.7

2.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.86

1.86

1.4

1.2

—

(1761868) Lipid panel - Serum or Plasma

676

7327

0.89

1.85

2.7

2.4

—

(3013512) EKG study

423

3770

1.15

1.85

3.3

3.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

3.54

1.84

1.7

1.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

115

1.83

1.1

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

130

1.78

1.81

1.3

1.4

157.88

163.78

pmol/l

0.09

130

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

828

0.72

1.79

1.5

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

116

1.82

1.78

1.1

1.0

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

109

1.84

1.77

2.8

2.6

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1743

16981

1.16

1.75

4.0

3.7

1.49

mmol/l

0.03

1658

16029

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.92

1.72

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

125

1.77

1.72

2.5

2.0

—

(3022689) Creatine [Moles/volume] in Urine

2.51

1.66

1.2

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

400

3585

1.14

1.62

1.5

—

(3020779) Urea [Moles/volume] in Serum or Plasma

132

1074

1.24

1.61

6.6

8.2

8.64

8.46

mmol/l

0.10

127

1027

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1.88

1.60

1.5

1.2

—

(3013637) Mi-2 Ab [Presence] in Serum

2.51

1.59

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.51

1.59

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.51

1.59

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.51

1.59

1.0

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

1.95

1.59

1.3

1.9

2.10

5.77

u/field

—

(4200892) Spirometry reversibility

116

933

1.26

1.57

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.83

1.57

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

1.85

1.56

3.4

3.6

—

(1002224) Polysomnography panel

110

881

1.26

1.55

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

157

0.44

1.55

1.0

—

(3037121) Protein [Mass/volume] in Urine

467

1.36

1.54

3.1

3.4

0.28

0.24

g/l

0.21

200

(3020876) Protein [Mass/time] in 24 hour Urine

138

1.67

1.52

2.5

2.7

1.83

1.71

g/24h

0.05

(3017509) Phencyclidine [Presence] in Urine

2.86

1.50

1.3

1.6

—

(3004451) EKG impression Narrative

2.16

1.50

1.1

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

234

1.50

1.49

1.2

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

234

1.50

1.49

1.2

1.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

235

1.50

1.47

1.6

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

235

1.50

1.47

1.6

1.7

—

(3028433) Virus identified in Specimen by Culture

2.23

1.46

1.0

1.2

—

(3036180) Methadone [Presence] in Urine

1.85

1.46

2.8

1.9

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.37

1.45

2.9

4.4

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.73

1.43

12.5

5.7

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

759

0.74

1.41

1.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

118

1.70

1.41

1.6

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

758

0.75

1.40

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

758

0.75

1.40

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

755

0.75

1.37

1.4

—

(3010937) Rubella virus Ab [Presence] in Serum

2.95

1.36

1.0

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

199

1.51

1.35

1.3

1.9

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

2.13

1.33

1.1

2.1

—

66365.14

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.13

1.33

2.7

2.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.74

1.31

1.4

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

137

1.61

1.29

1.0

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

114

1.67

1.28

2.4

2.9

43.58

54.55

0.97

100

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.09

1.27

1.0

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

501

1.31

1.27

1.3

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

345

1.37

1.27

1.4

23.91

26.12

u/l

0.20

289

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

160

0.50

1.24

1.0

1.7

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

2.23

1.24

1.9

39.35

44.71

ug/l

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

2.23

1.24

1.6

—

(3035320) C reactive protein [Mass/volume] in Body fluid

100

1.71

1.23

4.4

2.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

139

1.59

1.23

1.0

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.97

1.22

2.5

3.6

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

2.64

1.21

4.2

6.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.64

1.21

1.2

1.0

—

(3024928) Oxygen saturation in Venous blood

246

1.43

1.21

2.9

2.6

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

156

1.54

1.20

1.0

1.1

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

197

1.48

1.19

2.4

2.3

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.31

1.18

2.7

2.8

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.31

1.18

12.5

5.8

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.00

1.16

1.0

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

269

2409

1.13

1.5

1.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1674

16383

1.11

1.12

3.7

3.4

1.30

1.27

mmol/l

0.69

1583

15392

(3032773) Endomysium IgG Ab [Titer] in Serum

151

1.53

1.11

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

313

1.35

1.07

2.3

2.6

92.57

93.56

ug/min

0.01

197

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

1.65

1.06

1.5

1.8

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

384

1.31

1.04

1.2

1.5

0.36

0.40

nmol/l

0.23

302

(3052592) Norovirus Ag [Presence] in Stool

2.28

1.03

1.2

1.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.28

1.03

1.0

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

333

1.33

1.02

1.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

1.69

1.01

1.5

1.4

—

828643.75

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

107

1.59

0.99

1.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.18

0.98

1.2

1.7

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

2.18

0.98

1.0

1.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

249

1.37

0.98

1.1

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

121

1407

0.85

0.96

1.6

1.7

—

(37021550) Renin [Units/volume] in Plasma --upright

0.00

0.96

0.0

1.4

—

58.43

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.77

0.94

1.1

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.23

0.93

1.3

1.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.82

0.92

1.2

1.4

—

(3036489) Thrombin time

609

1.22

0.91

1.7

1.8

20.69

21.00

0.17

520

(40768441) Liver Pathology biopsy report

126

1.51

0.91

1.1

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

151

1.46

0.90

2.4

3.1

0.84

0.82

nmol/l

0.07

122

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

102

1.57

0.90

1.9

2.8

44.50

44.55

—

(3002079) Sodium [Moles/time] in 24 hour Urine

1.69

0.88

2.1

1.3

198.50

163.47

mmol/24h

0.65

(3000093) Morphology [Interpretation] in Blood Narrative

103

1.56

0.87

1.2

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

299

1.31

0.86

1.1

1.36

3.51

u/ml

2.05

180

(3006653) Thiamine [Moles/volume] in Blood

1.65

0.81

1.0

1.4

144.83

129.88

nmol/l

0.72

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

756

1.19

0.81

1.6

1.9

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

701

1.19

0.81

3.5

3.2

5.02

5.18

kpa

0.91

677

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.82

0.79

1.0

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

109

949

1.16

0.75

1.7

2.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

289

1.29

0.74

1.1

—

(3025130) Human papilloma virus identified in Specimen

334

1.26

0.73

1.7

1.8

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

2.00

0.72

1.6

1.4

0.45

0.28

ug/l

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

2.00

0.72

1.0

—

0.03

—

(4035726) Immunohistochemistry procedure

121

1370

0.88

0.72

1.3

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.58

0.71

1.3

1.5

—

(3009343) pH of Capillary blood

693

1.18

0.70

3.5

3.2

7.43

7.41

0.47

(3051611) Lipemic interference index of Serum or Plasma

143

1.40

0.70

2.1

3.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

436

1.22

0.70

1.2

1.1

0.93

2.29

u/ml

1.45

216

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

152

1.39

0.69

1.4

1.5

—

(3027008) Opiates [Presence] in Urine

109

957

1.15

0.69

1.7

2.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

1.60

0.68

1.5

1.4

1.98

2.65

nmol/l

0.27

(3027944) Amphetamines [Presence] in Urine

107

940

1.15

0.67

1.7

2.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

153

1.38

0.67

1.4

1.5

—

(3028300) Cannabinoids [Presence] in Urine

109

960

1.14

0.66

1.7

2.1

—

(3051593) INR in Capillary blood by Coagulation assay

1.79

0.66

1.0

12.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.62

0.65

1.2

1.5

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.73

0.64

3.0

2.0

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

1.73

0.64

1.0

1.1

0.32

184.96

mg/l

—

(3045142) Bone marrow Pathology biopsy report

153

0.65

0.62

1.2

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

471

1.19

0.61

1.6

2.1

4.54

4.75

iu/l

0.04

190

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.60

0.61

1.0

1.7

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

130

1.39

0.61

1.0

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

307

1.24

0.61

6.7

3.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

426

1.20

0.60

2.5

3.1

1.51

1.40

mg/l

0.37

404

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.50

0.59

1.0

1.1

—

(3011897) Casein IgE Ab [Units/volume] in Serum

1.72

0.57

1.5

1.1

0.09

0.12

u/ml

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

225

2085

1.09

0.57

1.8

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

127

1407

0.90

0.57

1.6

1.5

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.67

0.56

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.67

0.56

1.0

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.62

0.55

1.0

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

825

0.87

0.55

1.8

1.7

6.63

4.29

mg/l

0.48

584

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.50

0.54

1.3

1.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.50

0.54

1.0

1.3

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

448

0.82

0.53

4.6

3.2

24.93

24.84

mmol/l

0.07

413

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.54

0.53

1.0

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.54

0.53

1.0

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

152

1.32

0.52

1.4

1.5

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

650

0.86

0.51

2.0

1.7

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

668

1.14

0.51

3.4

3.1

1.90

1.76

mmol/l

0.14

500

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

324

1.21

0.51

1.5

1.6

—

(3011648) Oxygen content in Venous blood

101

1.39

0.49

2.8

1.7

11.51

11.57

0.01

101

(40768806) Pleura Pathology biopsy report

111

0.63

0.48

1.1

1.5

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

245

0.77

0.48

4.9

5.9

332.79

386.11

umol/l

0.93

216

(3019832) Treponema pallidum Ab [Presence] in Serum

263

2481

1.07

0.45

1.6

1.7

—

(3016018) Differential panel - Cerebral spinal fluid

165

1.28

0.45

1.1

1.5

—

(3028707) Methadone [Presence] in Urine by Screen method

367

1.18

0.44

2.3

3.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

434

1.16

0.42

3.7

4.4

49.57

840.25

u/ml

1.29

381

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.63

0.42

1.5

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

158

1.27

0.41

1.4

1.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

249

1.21

0.41

1.6

—

(3016879) Cocaine [Presence] in Urine

872

1.11

0.41

1.7

2.2

—

(3019174) dRVVT (LA screen)

0.00

0.40

0.0

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

159

1.26

0.40

1.4

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

159

1.26

0.40

1.4

1.5

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.00

0.39

0.0

1.9

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

514

1.13

0.38

1.6

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

125

1.28

0.37

2.4

3.5

—

(3002256) Pathology report gross observation

215

2034

1.06

0.36

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

1.34

0.35

1.2

1.4

6.57

6.41

mmol/l

0.08

(40768795) Lymph node Pathology biopsy report

168

0.77

0.35

1.5

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

266

0.83

0.35

1.5

1.6

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

1.40

0.35

1.7

1.4

301.20

141.96

nmol/l

—

(3022313) Gas panel - Capillary blood

520

0.88

0.33

4.1

3.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

293

1.16

0.33

1.1

3.81

4.48

u/ml

0.13

116

(3019225) pH of Specimen

119

1275

0.93

0.31

3.9

3.8

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

324

1.14

0.30

1.1

2.43

3.24

u/ml

0.29

152

(3035933) Granulocytes/100 leukocytes in Blood

1.29

0.28

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

460

1.11

0.28

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

367

1.12

0.26

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

367

1.12

0.26

1.1

—

(40768800) Prostate Pathology biopsy report

160

0.81

0.26

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

232

0.86

0.23

1.1

1.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.25

0.22

1.0

1.9

—

(3044007) Cell count panel - Peritoneal fluid

1.22

0.22

1.4

2.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.19

0.21

1.0

2.7

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

2.1

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.21

0.0

1.7

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

3.9

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

4.1

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

0.00

0.21

0.0

1.6

—

28.80

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

382

1.10

0.21

1.3

1.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.21

0.0

1.8

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

12.2

—

136.43

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

0.21

0.0

2.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

103

0.78

0.21

1.3

1.6

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

1.16

0.21

1.4

1.1

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

0.00

0.21

0.0

1.3

—

10.83

—

(3011288) Drugs identified in Urine by Screen method

634

1.07

0.21

1.8

3.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.25

0.20

1.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.00

0.20

0.0

1.3

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

0.00

0.20

0.0

2.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

194

1.14

0.18

1.9

1.6

8.05

7.69

mmol/l

0.38

184

(3017569) Oxygen content in Arterial blood

1.21

0.18

1.1

3.5

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

121

0.83

0.18

1.4

1.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

131

1257

1.04

0.17

3.6

4.5

94.02

47.11

ug/l

0.21

100

977

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

110

1.18

0.17

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

728

1.06

0.17

1.8

2.1

—

(40768446) Kidney Pathology biopsy report

0.76

0.17

2.4

1.6

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.16

0.16

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

1.20

0.16

1.2

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

178

1.12

0.15

3.0

5.0

292.70

61.49

u/ml

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.11

0.15

1.0

1.9

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

179

1.12

0.14

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

363

1.08

0.14

1.1

1.31

1.92

u/ml

0.43

174

(3020874) Milk IgE Ab [Units/volume] in Serum

132

1.14

0.13

1.1

1.0

0.34

4.56

u/ml

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

668

1.05

0.12

1.5

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

157

0.89

0.11

1.4

1.3

0.88

0.98

g/l

1.76

157

(3003694) ABO and Rh group [Type] in Blood

516

5097

1.02

0.11

1.5

1.6

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.16

0.11

1.1

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

348

1.06

0.10

1.6

1.3

6.93

4.01

ug/l

0.35

320

(40768793) Breast Pathology biopsy report

423

0.94

0.10

1.1

1.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.11

0.09

1.0

1.2

—

(3035880) pH of Pleural fluid

1.11

0.09

1.2

1.3

—

(3033799) Differential panel - Peritoneal fluid

1.09

0.09

1.4

2.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

114

0.88

0.09

4.6

7.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.15

0.09

2.1

1.9

—

(3003434) Protein [Mass/volume] in Pleural fluid

116

1.12

0.09

1.2

1.5

26.60

31.76

g/l

0.65

105

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

329

0.94

0.09

1.2

—

(3024471) HLA-A [Type]

0.82

0.08

1.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

0.78

0.08

1.2

—

(3034426) Prothrombin time (PT)

1.06

0.08

1.3

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

0.86

0.07

1.2

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

0.86

0.07

1.0

1.1

—

5.79

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

180

1832

0.98

0.07

2.7

2.6

0.66

0.73

ug/l

0.61

1045

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.80

0.07

1.0

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.80

0.07

1.0

1.9

—

(21494434) Karyotype in Bone marrow

108

1.11

0.07

1.2

1.3

—

(3045788) Cell count panel - Pleural fluid

0.82

0.07

1.3

1.4

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.11

0.06

1.2

1.6

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

375

1.04

0.05

1.1

0.45

1.58

u/ml

1.37

158

(3045683) HLA typing for celiac disease panel - Blood or Tissue

139

1.08

0.05

1.1

1.0

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

111

1.08

0.04

2.8

31248.72

41077.48

ug/l

0.85

111

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

121

1.07

0.03

1.6

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

121

1.07

0.03

1.6

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

121

1.07

0.03

1.6

1.7

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

331

0.97

0.03

3.0

3.3

21.44

22.68

mg/l

0.09

206

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

141

1.06

0.03

1.5

1.8

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

149

0.94

0.03

1.4

1.3

1.64

1.61

g/l

0.25

149

(3050129) First trimester maternal screen panel - Serum or Plasma

931

0.99

0.02

1.5

1.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

247

0.97

0.01

2.1

2.6

—

(4094501) Cardiovascular stress test using bicycle ergometer

393

1.02

0.01

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

757

0.99

0.01

1.5

—

(3051651) Icteric interference index of Serum or Plasma

104

1.06

0.01

1.5

3.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

104

1.06

0.01

1.1

1.2

—

(4281824) Cell count and differential, peritoneal fluid

176

0.97

0.00

1.3

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

119

1.01

0.00

1.2

1.3

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

295

0.98

0.00

1.2

1.1

7.00

1654.57

iu/ml

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

591

1.00

0.00

1.8

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

124

0.97

0.00

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

154

0.97

0.00

1.5

1.7

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

264

0.98

0.00

1.1

0.01

0.38

u/ml

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

354

0.99

0.00

1.2

1.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

396

1.01

0.00

1.1

3.61

5.55

u/ml

0.55

204

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

122

0.98

0.00

2.3

2.6

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

132

0.98

0.00

1.5

1.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

127

1.02

0.00

1.8

1.6

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.90

0.00

1.3

3.0

—

(3012441) Differential panel - Pleural fluid

0.93

0.00

1.2

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

0.88

-0.00

1.3

1.9

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

0.94

-0.00

1.0

1.3

6.67

11.08

u/l

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.02

-0.00

1.6

1.5

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.3

—

(40763590) HLA-DQ beta [Type]

0.00

-0.00

0.0

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

-0.00

0.0

1.0

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.02

-0.00

1.6

1.5

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

1.1

—

37.81

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

0.88

-0.00

1.3

1.9

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.92

-0.00

1.2

2.6

—

(3047185) IgG [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

-0.00

0.0

1.9

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.00

-0.00

1.0

1.2

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

-0.00

0.0

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

180

1.00

-0.00

1.8

1.5

—

(40760410) HLA-B [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(3047189) Immunofixation for 24 hour Urine

1.00

-0.00

1.0

2.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

2.00

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

-0.00

0.0

3.5

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

(46236302) HLA-C [Type] by High resolution typing

0.00

-0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

-0.00

0.0

5.1

—

406.13

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

-0.00

0.0

1.7

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.88

-0.00

2.7

3.2

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

-0.00

0.0

1.9

—

1.61

—

(40760409) HLA-A [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.2

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

13.3

—

(3013762) Body weight Measured

0.00

-0.00

0.0

1.4

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

1.1

—

8.25

—

(3022725) Serotonin [Moles/volume] in Serum

0.00

-0.00

0.0

1.5

—

3319.00

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

1.1

—

22.16

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

-0.00

0.0

2.0

—

(3007463) Buprenorphine [Presence] in Urine

0.00

-0.00

0.0

2.4

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_SPONDYLINFLAMNAS and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_SPONDYLINFLAMNAS	1.224 [1.04, 1.44]	0.014
Birth year	1.0 [0.99, 1.01]	0.97

During the follow-up period (1.1.1998 — 31.12.2019), 297 out of 5780 females with M13_SPONDYLINFLAMNAS died.

Males

Parameter	HR [95% CI]	p-value
M13_SPONDYLINFLAMNAS	1.518 [1.31, 1.76]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.005

During the follow-up period (1.1.1998 — 31.12.2019), 390 out of 3635 males with M13_SPONDYLINFLAMNAS died.

Mortality risk

Mortality risk for people of age

years, who have M13_SPONDYLINFLAMNAS.

N-year risk	Females	Males
1	0.084%	0.256%
5	0.817%	1.557%
10	2.133%	4.122%
15	4.094%	7.724%
20	7.452%	13.285%

Relationships between endpoints

↥

Index endpoint: M13_SPONDYLINFLAMNAS – Other specified/unspecified inflammatory spondylopathies

GWS hits: 4

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other specified/unspecified inflammatory spondylopathies

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints